<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC10732409</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0295919</article-id><article-id pub-id-type="publisher-id">PONE-D-23-03991</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Obesity</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Body Mass Index</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Overweight</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Medical Risk Factors</subject><subj-group><subject>Cancer Risk Factors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Risk Factors</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Population Biology</subject><subj-group><subject>Population Metrics</subject><subj-group><subject>Death Rates</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Cardiovascular Diseases</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Cardiovascular Medicine</subject><subj-group><subject>Cardiovascular Diseases</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>BMI trajectory in adulthood in relation to all-cause and cause-specific mortality: A retrospective cohort study in Taiwan</article-title><alt-title alt-title-type="running-head">BMI trajectory in adulthood and the cause-specific mortality</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chiu</surname><given-names>Po-Wei</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/software/">Software</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="aff001" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Tsung</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Kukreti</surname><given-names>Shikha</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2934-5382</contrib-id><name><surname>Strong</surname><given-names>Carol</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff"/><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001">
<addr-line>Department of Public Health, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Masanovic</surname><given-names>Bojan</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Montenegro, MONTENEGRO</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>carol.chiajung@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>18</volume><issue>12</issue><elocation-id>e0295919</elocation-id><history><date date-type="received"><day>11</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>30</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 Chiu et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Chiu et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0295919.pdf"/><abstract><p>A dynamic change of weight over time has been known as an important factor that impacts mortality risk. The aims of this study were to identify the heterogeneity of BMI trajectory groups and to examine the association of the trajectories of BMI and all-cause and cause-specific mortality. The data for this study were obtained from a large prospective cohort study in Taiwan between 1998 and 2019 that was linked to the National Death Registry for death information. The participants were stratified into four groups by age and gender; self-reported demographics and measured BMI data were used. We used group-based trajectory analysis to identify the distinct trajectories of changes in BMI. A Cox proportional hazards model was used to assess the hazard ratio (HR) of all-cause and cause-specific mortality risk. Data were analyzed in April 2020 and included 89,886 participants. Four trajectory groups were identified by the pattern of BMI change over time. Our study shows that different trajectories were associated with mortality. Our findings suggest that the mortality risk differs in each trajectory group and in each age and gender stratification. It appears that obesity is a protective factor in cancer-related mortality in females but not in males in group of old age participants; low-normal weight is a risk factor in respiratory-related mortality in all participants. Our findings can be used to suggest the appropriate BMI in each age and gender groups and thereby earlier health interventions can be taken to avoid mortality.</p></abstract><funding-group><award-group id="award001"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100020363</institution-id><institution>Institute for Information Industry, Ministry of Science and Technology, Taiwan</institution></institution-wrap>
</funding-source><award-id>MOST 108-2636-B-006-004, MOST 109-2636-B-006-004, MOST 110-2636-B-006-011, MOST 111-2636-B-006-011</award-id><principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2934-5382</contrib-id>
<name><surname>Strong</surname><given-names>Carol</given-names></name>
</principal-award-recipient></award-group><award-group id="award002"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100020363</institution-id><institution>Institute for Information Industry, Ministry of Science and Technology, Taiwan</institution></institution-wrap>
</funding-source><award-id>MOST 108-2636-B-006-004, MOST 109-2636-B-006-004, MOST 110-2636-B-006-011, MOST 111-2636-B-006-011</award-id><principal-award-recipient>Po-Wei chui</principal-award-recipient></award-group><award-group id="award003"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100020363</institution-id><institution>Institute for Information Industry, Ministry of Science and Technology, Taiwan</institution></institution-wrap>
</funding-source><award-id>MOST 108-2636-B-006-004, MOST 109-2636-B-006-004, MOST 110-2636-B-006-011, MOST 111-2636-B-006-011</award-id><principal-award-recipient>
<name><surname>Kukreti</surname><given-names>Shikha</given-names></name>
</principal-award-recipient></award-group><award-group id="award004"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100020363</institution-id><institution>Institute for Information Industry, Ministry of Science and Technology, Taiwan</institution></institution-wrap>
</funding-source><award-id>MOST 108-2636-B-006-004, MOST 109-2636-B-006-004, MOST 110-2636-B-006-011, MOST 111-2636-B-006-011</award-id><principal-award-recipient>
<name><surname>Yu</surname><given-names>Tsung</given-names></name>
</principal-award-recipient></award-group><funding-statement>All of the authors received funding by the Taiwan Ministry of Science and Technology (MOST 108-2636-B-006-004, MOST 109-2636-B-006-004, MOST 110-2636-B-006-011, MOST 111-2636-B-006-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="4"/><page-count count="15"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>Data can be accessed publicly by an application process at <ext-link xlink:href="http://www.mjhrf.org/main/index/en" ext-link-type="uri">http://www.mjhrf.org/main/index/en</ext-link>. These are third party data and can be accessed with an application process at <ext-link xlink:href="http://www.mjhrf.org/main/index/en" ext-link-type="uri">http://www.mjhrf.org/main/index/en</ext-link>. Authors did not have any special access privileges that others would not have.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>Data can be accessed publicly by an application process at <ext-link xlink:href="http://www.mjhrf.org/main/index/en" ext-link-type="uri">http://www.mjhrf.org/main/index/en</ext-link>. These are third party data and can be accessed with an application process at <ext-link xlink:href="http://www.mjhrf.org/main/index/en" ext-link-type="uri">http://www.mjhrf.org/main/index/en</ext-link>. Authors did not have any special access privileges that others would not have.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>A dynamic change of weight over time has been known as an important factor of mortality risk, especially among older adults [<xref rid="pone.0295919.ref001" ref-type="bibr">1</xref>]. Body mass index (BMI) trajectory studies can highlight the importance of initial weight status and the amount of weight gain in relation to mortality. In a study that examined BMI trajectory in an elderly adult sample in the United States (US), small weight gain (defined as less than 10 kilograms) was not associated with increasing mortality risk, regardless of the patients&#x02019; initial BMI, whereas a large weight gain increased the mortality risk when the initial BMI was greater than 35 kilograms [<xref rid="pone.0295919.ref002" ref-type="bibr">2</xref>]. However, most of the trajectory studies focused on all-cause mortality. It is important to investigate the different causes of death among groups of different BMI because cancer and cardiovascular disease deaths may be related to BMI [<xref rid="pone.0295919.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0295919.ref004" ref-type="bibr">4</xref>].</p><p>The association between change of BMI and mortality risk has been reported as &#x0201c;reverse J shape&#x0201d; since underweight and obesity are associated with increased mortality risk [<xref rid="pone.0295919.ref005" ref-type="bibr">5</xref>]. Overweight, however, has sometimes been found to have a protective effect to all-cause mortality rate among elderly, which is known as the &#x0201c;obesity paradox&#x0201d; [<xref rid="pone.0295919.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="pone.0295919.ref008" ref-type="bibr">8</xref>]. Overweight groups have the lowest risk of death in both Japan and Western populations [<xref rid="pone.0295919.ref005" ref-type="bibr">5</xref>]. In several US samples, the association differs by the amount of weight change. Modest weight gains are associated with a significantly decreased mortality risk, whereas excessive weight gains predict a significantly increased mortality risk [<xref rid="pone.0295919.ref005" ref-type="bibr">5</xref>]. The literature regarding the obesity paradox is not consistent. Some studies have evidence against this phenomenon [<xref rid="pone.0295919.ref009" ref-type="bibr">9</xref>], and consider it as a phenomenon of reverse causality that a low BMI population may undergo illness such as cancer or severe infection.</p><p>Several types of diseases are negatively related to obesity and overweight such as cardiovascular disease (CVD) [<xref rid="pone.0295919.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0295919.ref011" ref-type="bibr">11</xref>], certain types of cancer such as breast, colon, and uterine cancers [<xref rid="pone.0295919.ref012" ref-type="bibr">12</xref>]. Yet, obesity and overweight are protective factors for respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma [<xref rid="pone.0295919.ref013" ref-type="bibr">13</xref>]. Further, differences in the BMI level, pattern of weight change, and cause of death have been found in different age and gender groups using group-based trajectory analysis [<xref rid="pone.0295919.ref014" ref-type="bibr">14</xref>], a method that identifies the distinct trajectories of changes in BMI. Overweight or obese trajectory groups in younger adulthood (age 40&#x02013;60) were more likely to have numerous health conditions especially on cardiovascular disease and to have higher mortality rates. Overweight or obesity in older age (age 60+) groups, however, were found to be protective factors against mortality [<xref rid="pone.0295919.ref015" ref-type="bibr">15</xref>]. In addition, one study revealed that men tended to have a higher risk of developing life-threatening conditions&#x02014;especially obesity-related deaths such as heart disease and diabetes. Conversely, women were more susceptible to debilitating but non-fatal conditions such as arthritis and depression [<xref rid="pone.0295919.ref016" ref-type="bibr">16</xref>].</p><p>In order to better access the effects of weight pattern changes over time, it is essential to examine the all-cause and cause-specific mortality risk consequences of BMI trajectories. Identification of cause-specific mortality risk in different BMI trajectories can facilitate our understanding of the details behind the &#x0201c;obesity paradox.&#x0201d;</p><p>The present study has two specific aims. First, we applied group-based trajectory models to explore the heterogeneity of the BMI trajectory throughout eighteen years in adulthood among Taiwanese adults over 40 years of age. Studies have identified different trajectory groupings and mortality rates for men and women and for adults in ages 40&#x02013;60 compared to age 60+ [<xref rid="pone.0295919.ref015" ref-type="bibr">15</xref>]. For example, in a sample of Canadian adults, men tended to maintain a stable BMI trajectory; women were more likely to experience a decrease in BMI over time, which may be related to the differences in hormones and body composition between genders [<xref rid="pone.0295919.ref015" ref-type="bibr">15</xref>]. Therefore, we hypothesized that different trajectory groups would be identified by age and sex groups. Second, we examined the relationship between the trajectories of BMI and all-cause and cause-specific mortality. Specifically, some causes of deaths such as CVD and cancer are associated with the trajectory that is consistently overweight or obese, but respiratory disease as cause of death is associated with a lower BMI trajectory. We also explored the differences in the association between BMI trajectory and mortality stratified by gender and age groups.</p></sec><sec id="sec002"><title>Materials/Subjects and methods</title><sec id="sec003"><title>Participants</title><p>This research was conducted using the Taiwan Mei-Jao (MJ) Cohort resource, which is a longitudinal, population-based health dataset run by the MJ Health Management Institution, Taiwan [<xref rid="pone.0295919.ref017" ref-type="bibr">17</xref>]. The details of the MJ Cohort population and data collection are reported elsewhere [<xref rid="pone.0295919.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="pone.0295919.ref021" ref-type="bibr">21</xref>]. According to the cohort profile [<xref rid="pone.0295919.ref022" ref-type="bibr">22</xref>], MJ is a membership which is a private fee-for-service company offering comprehensive health screening programs. The MJ cohort has enrolled around 600,000 Taiwanese individuals since 1994. Participants of the MJ cohort receive health examinations including self-reported questionnaires on medical, social, and family history as well as demographic information, and undergo a series of medical tests that include complete blood cell count, differential count, biochemistry tests, and physical examinations. The MJ Health Management Institution was authorized by every participant to process the data produced from their medical screening through the signing of a consent form [<xref rid="pone.0295919.ref022" ref-type="bibr">22</xref>].</p><p>The details of participant selection for the present study are shown in <xref rid="pone.0295919.g001" ref-type="fig">Fig 1</xref>. The database accumulated 290,279 participants who first went to the MJ cohort between 1998 and 2006. Of the included participants, we obtained all their data collected from the year they first went to the MJ cohort to year 2017. Setting three years as an interval, we built a 7-wave longitudinal dataset; an interval of a seventh wave has only 2 years, 2016&#x02013;2017). If two or more measurements for one person were accessible within one interval, the measurement closest to the center of the interval was chosen. We excluded those who were less than 40 years old in 1998 (n = 51,731), less than two waves follow-up (n = 145,270), and who had ever been diagnosed at baseline with any of the following self-reported conditions: cancer, stroke (n = 3,392). The final study sample included 89,886 participants. We separated the participants into 4 groups by sex (male and female) and age (40- to 60-year-old and more than 60-year-old).</p><fig position="float" id="pone.0295919.g001"><object-id pub-id-type="doi">10.1371/journal.pone.0295919.g001</object-id><label>Fig 1</label><caption><title>Patient attrition and cohort selection.</title><p>Inclusion and exclusion criteria show cohort selection for the MJ cohort dataset.</p></caption><graphic xlink:href="pone.0295919.g001" position="float"/></fig><p>Death information was based on the National Death Registry obtained from the Ministry of Health and Welfare, Taiwan, and was linked to the MJ cohort. All deaths were identified from death certificates and were confirmed by trained physicians. Follow-up time for mortality started at the date of each participant&#x02019;s first measurement and was censored by October 31, 2019, the date when we linked death information to the MJ cohort. We categorized the cause of mortality into three leading causes: &#x0201c;cancer,&#x0201d; including all kinds of cancer, &#x0201c;cardiovascular disease,&#x0201d; and &#x0201c;respiratory disease.&#x0201d; All other causes of death were grouped into the category &#x0201c;Other.&#x0201d;</p></sec><sec id="sec004"><title>Mortality</title><p>This analysis focused on 2 separate outcome measures: (1) hazard of all-cause mortality in distinct groups, and (2) hazard of cause-specific mortality in distinct groups.</p></sec><sec id="sec005"><title>BMI</title><p>Body height and weight were measured at every follow-up visit for each participant and BMI was calculated by dividing the weight (in kilograms) by their height squared (in meters). According to the BMI classification by the World Health Organization (WHO), BMI above 30 (kg/m<sup>2</sup>) should be classified as obesity, whereas BMI between 25 and 30 should be classified as overweight; BMI below 18.5 was classified as underweight [<xref rid="pone.0295919.ref023" ref-type="bibr">23</xref>].</p></sec><sec id="sec006"><title>Covariate variables</title><p>Age, smoking status, alcohol consumption, educational level, and physical activity at baseline were obtained from the self-reported questionnaire from the MJ cohort and were incorporated as covariates in the present study. Age was defined at the year of 1998. Smoking status and alcohol consumption were both classified into three categories: never smoker/drinker, former smoker/drinker, and current smoker/drinker. The educational level was classified into two categories: high school or less, and college or above. Physical activity was classified into three categories: seldom (exercise less than two hours a week), sometimes (exercise between two and five hours a week), and frequent (exercise more than five hours a week).</p></sec><sec id="sec007"><title>Statistical methods</title><p>Descriptive statistics (mean, standard deviation, and percentages) were used to summarize the demographic and clinical characteristics of participants. We used a group-based trajectory model with maximum likelihood estimation to identify the distinct trajectories of changes in BMI using the SAS PROC TRAJ program (SAS Institute, Inc., Cary, North Carolina) [<xref rid="pone.0295919.ref024" ref-type="bibr">24</xref>]. As recommended, we estimated models with 2&#x02013;5 trajectories by assuming linear, quadratic, and cubic patterns of change in BMI over time and the best-fitting model (the number of distinct trajectories and the patterns of change in BMI) was determined on the basis of Bayesian Information Criterion scores(BIC) [<xref rid="pone.0295919.ref025" ref-type="bibr">25</xref>].</p><p>The hazard ratio (HR) of all-cause mortality was analyzed using a Cox proportional hazards model, including BMI trajectory groups, and the previously mentioned covariates including age, smoking status, alcohol consumption, educational levels, and physical activity. We used the time from baseline as the time scale to parameterize the baseline hazard function [<xref rid="pone.0295919.ref026" ref-type="bibr">26</xref>] because different birth cohorts were observed at different ages. The analyses were performed using the SAS PROC PHREG program.</p><p>A cause-specific hazards model was used to assess the HR of cause-specific mortality. This model can be estimated by censoring participants with the competing event and then fitting the standard Cox proportional hazards model [<xref rid="pone.0295919.ref027" ref-type="bibr">27</xref>]. The analyses were performed using the SAS PROC PHREG program.</p></sec></sec><sec sec-type="results" id="sec008"><title>Results</title><p>Of all 89,886 participants, 53.3% were women, 82.5% were between 40 and 60 years of age (<xref rid="pone.0295919.t001" ref-type="table">Table 1</xref>). Mean age was 55.2 (year-old) and mean BMI was 24.1 (kg/m<sup>2</sup>). The mean follow-up time was 16.8 years; 14.2 years for participants aged over 60 and 17.3 years for participants aged between 40 and 60. A quarter of participants had a college degree, but a much lower proportion of women aged over 60 obtained a college degree (3.8%). In terms of lifestyle factors, women were more likely to be never smokers or never drinkers, regardless of age groups. Overall, 38.3% had a seldom level of physical activity, 18.6% were sometimes, and 35.5% were frequent.</p><table-wrap position="float" id="pone.0295919.t001"><object-id pub-id-type="doi">10.1371/journal.pone.0295919.t001</object-id><label>Table 1</label><caption><title>Baseline characteristics by the subgroups classify by gender and age.</title></caption><alternatives><graphic xlink:href="pone.0295919.t001" id="pone.0295919.t001g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Male aged over 60</th><th align="center" rowspan="1" colspan="1">Male aged 40&#x02013;60</th><th align="center" rowspan="1" colspan="1">Female aged over 60</th><th align="center" rowspan="1" colspan="1">Female aged 40&#x02013;60</th><th align="center" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">People count, number</td><td align="center" rowspan="1" colspan="1">8140</td><td align="center" rowspan="1" colspan="1">33790</td><td align="center" rowspan="1" colspan="1">7621</td><td align="center" rowspan="1" colspan="1">40335</td><td align="center" rowspan="1" colspan="1">89886</td></tr><tr><td align="left" rowspan="1" colspan="1">Age, mean(SD), years</td><td align="center" rowspan="1" colspan="1">70.1 (5.3)</td><td align="center" rowspan="1" colspan="1">51.9 (6.5)</td><td align="center" rowspan="1" colspan="1">69.5 (5.3)</td><td align="center" rowspan="1" colspan="1">52.3 (6.2)</td><td align="center" rowspan="1" colspan="1">55.2 (9.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Person-year, mean(SD), person-years</td><td align="center" rowspan="1" colspan="1">14.2 (5.4)</td><td align="center" rowspan="1" colspan="1">17.2 (3.6)</td><td align="center" rowspan="1" colspan="1">15.5 (4.9)</td><td align="center" rowspan="1" colspan="1">17.4 (3.3)</td><td align="center" rowspan="1" colspan="1">16.9 (3.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of people died during follow-up</td><td align="center" rowspan="1" colspan="1">4498 (55.3)</td><td align="center" rowspan="1" colspan="1">3987 (11.8)</td><td align="center" rowspan="1" colspan="1">3100 (40.7)</td><td align="center" rowspan="1" colspan="1">2863 (7.1)</td><td align="center" rowspan="1" colspan="1">14448</td></tr><tr><td align="left" rowspan="1" colspan="1">Cause of death</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">Cancer(%)<xref rid="t001fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">1366 (30.4)</td><td align="center" rowspan="1" colspan="1">1805 (45.3)</td><td align="center" rowspan="1" colspan="1">813 (26.2)</td><td align="center" rowspan="1" colspan="1">1437 (50.2)</td><td align="center" rowspan="1" colspan="1">5421 (37.5)</td></tr><tr><td align="center" rowspan="1" colspan="1">Cardiovascular disease(%)<xref rid="t001fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">1062 (23.6)</td><td align="center" rowspan="1" colspan="1">748 (18.8)</td><td align="center" rowspan="1" colspan="1">801 (25.8)</td><td align="center" rowspan="1" colspan="1">438 (15.3)</td><td align="center" rowspan="1" colspan="1">3049 (21.1)</td></tr><tr><td align="center" rowspan="1" colspan="1">Respiratory disease(%)<xref rid="t001fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">652 (14.5)</td><td align="center" rowspan="1" colspan="1">197 (4.9)</td><td align="center" rowspan="1" colspan="1">286 (9.2)</td><td align="center" rowspan="1" colspan="1">110 (3.8)</td><td align="center" rowspan="1" colspan="1">1245 (8.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">Others(%)<xref rid="t001fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">1418 (31.5)</td><td align="center" rowspan="1" colspan="1">1237 (31)</td><td align="center" rowspan="1" colspan="1">1200 (38.7)</td><td align="center" rowspan="1" colspan="1">878 (30.7)</td><td align="center" rowspan="1" colspan="1">4733 (32.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI, mean(SD)</td><td align="center" rowspan="1" colspan="1">23.7 (3.1)</td><td align="center" rowspan="1" colspan="1">24.4 (3.0)</td><td align="center" rowspan="1" colspan="1">24.6 (3.5)</td><td align="center" rowspan="1" colspan="1">23.7 (3.4)</td><td align="center" rowspan="1" colspan="1">24.0 (3.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking status, number(%)<xref rid="t001fn002" ref-type="table-fn"><sup>b</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">Never</td><td align="center" rowspan="1" colspan="1">3504 (45.6)</td><td align="center" rowspan="1" colspan="1">15611 (48.7)</td><td align="center" rowspan="1" colspan="1">6893 (95.5)</td><td align="center" rowspan="1" colspan="1">36416 (95.3)</td><td align="center" rowspan="1" colspan="1">62424 (73.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Former</td><td align="center" rowspan="1" colspan="1">1648 (21.4)</td><td align="center" rowspan="1" colspan="1">4114 (12.8)</td><td align="center" rowspan="1" colspan="1">111 (1.5)</td><td align="center" rowspan="1" colspan="1">312 (0.8)</td><td align="center" rowspan="1" colspan="1">6185 (7.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Current</td><td align="center" rowspan="1" colspan="1">2535 (33.0)</td><td align="center" rowspan="1" colspan="1">12351 (38.5)</td><td align="center" rowspan="1" colspan="1">215 (3.0)</td><td align="center" rowspan="1" colspan="1">1475 (3.9)</td><td align="center" rowspan="1" colspan="1">16576 (19.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Alcohol comsuption, number(%)<xref rid="t001fn003" ref-type="table-fn"><sup>c</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">Never</td><td align="center" rowspan="1" colspan="1">4546 (61.3)</td><td align="center" rowspan="1" colspan="1">18517 (59.1)</td><td align="center" rowspan="1" colspan="1">6459 (95.8)</td><td align="center" rowspan="1" colspan="1">32556 (91.9)</td><td align="center" rowspan="1" colspan="1">62078 (76.7)</td></tr><tr><td align="center" rowspan="1" colspan="1">Former</td><td align="center" rowspan="1" colspan="1">886 (12.0)</td><td align="center" rowspan="1" colspan="1">2061 (6.6)</td><td align="center" rowspan="1" colspan="1">97 (1.4)</td><td align="center" rowspan="1" colspan="1">629 (1.8)</td><td align="center" rowspan="1" colspan="1">3673 (4.5)</td></tr><tr><td align="center" rowspan="1" colspan="1">Current</td><td align="center" rowspan="1" colspan="1">1981 (26.7)</td><td align="center" rowspan="1" colspan="1">10779 (34.4)</td><td align="center" rowspan="1" colspan="1">189 (2.8)</td><td align="center" rowspan="1" colspan="1">2254 (6.4)</td><td align="center" rowspan="1" colspan="1">15203 (18.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Education level, number(%)<xref rid="t001fn004" ref-type="table-fn"><sup>d</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">High school or less</td><td align="center" rowspan="1" colspan="1">6046 (79.0)</td><td align="center" rowspan="1" colspan="1">18720 (58.1)</td><td align="center" rowspan="1" colspan="1">6950 (96.0)</td><td align="center" rowspan="1" colspan="1">31500 (81.6)</td><td align="center" rowspan="1" colspan="1">63216 (73.8)</td></tr><tr><td align="center" rowspan="1" colspan="1">College or above</td><td align="center" rowspan="1" colspan="1">1604 (21.0)</td><td align="center" rowspan="1" colspan="1">13487 (41.9)</td><td align="center" rowspan="1" colspan="1">288 (4.0)</td><td align="center" rowspan="1" colspan="1">7088 (18.4)</td><td align="center" rowspan="1" colspan="1">22467 (26.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Physical activity, number(%)<xref rid="t001fn005" ref-type="table-fn"><sup>e</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">Seldom</td><td align="center" rowspan="1" colspan="1">2372 (31.9)</td><td align="center" rowspan="1" colspan="1">12370 (39.7)</td><td align="center" rowspan="1" colspan="1">2612 (37.0)</td><td align="center" rowspan="1" colspan="1">17065 (45.8)</td><td align="center" rowspan="1" colspan="1">34219 (41.4)</td></tr><tr><td align="center" rowspan="1" colspan="1">Sometimes</td><td align="center" rowspan="1" colspan="1">1113 (15.0)</td><td align="center" rowspan="1" colspan="1">6798 (21.8)</td><td align="center" rowspan="1" colspan="1">1201 (17.0)</td><td align="center" rowspan="1" colspan="1">7631 (20.5)</td><td align="center" rowspan="1" colspan="1">16743 (20.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Frequent</td><td align="center" rowspan="1" colspan="1">3952 (53.1)</td><td align="center" rowspan="1" colspan="1">11983 (38.5)</td><td align="center" rowspan="1" colspan="1">3243 (46.0)</td><td align="center" rowspan="1" colspan="1">12526 (33.7)</td><td align="center" rowspan="1" colspan="1">31704 (38.4)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><sup>a</sup>The denominator of the proportion is the total number of death for each column.</p></fn><fn id="t001fn002"><p><sup>b</sup>missing data 4701 (5.0%).</p></fn><fn id="t001fn003"><p><sup>c</sup>missing data 8932 (9.9%).</p></fn><fn id="t001fn004"><p><sup>d</sup>missing data 4203 (4.6%).</p></fn><fn id="t001fn005"><p><sup>e</sup>missing data 7020 (7.8%).</p></fn></table-wrap-foot></table-wrap><p>As shown in <xref rid="pone.0295919.t001" ref-type="table">Table 1</xref>, 14,448 participants (16.1%) died during follow-up; the majority of deaths were caused by cancer (37.5%), followed by others (32.7%), cardiovascular disease (21.1%), and respiratory disease (8.6%). Both men and women in the age group of 40&#x02013;60 had a higher proportion of cancer deaths than their counterparts in the age group of 60 or above (men: 45.3% (aged 40&#x02013;60) vs. 30.4% (aged over 60); women: 50.2% (aged 40&#x02013;60) vs. 26.2% [aged over 60]).</p><p>In the trajectory analysis, each of the four groups was identified by four trajectory groups based on BIC (Bayesian Information Criterion scores). In <xref rid="pone.0295919.t002" ref-type="table">Table 2</xref>, we presented the intercept, slope, and group membership for each trajectory group by age and sex. <xref rid="pone.0295919.g002" ref-type="fig">Fig 2a</xref> to 2d illustrate the trajectories of BMI in four distinct groups derived from group-based trajectory models; solid lines indicate the mean values of BMI. We differentiated the four trajectory groups as obesity, overweight, mid-normal weight, and low-normal weight based on the intercept displayed in <xref rid="pone.0295919.t002" ref-type="table">Table 2</xref>. The linear slope was used to differentiate a stable or increasing trend. Mid-normal weight, regardless of a stable or an increasing trend, was the largest trajectory group for each age and sex group: 42.7%-47.2% (<xref rid="pone.0295919.t002" ref-type="table">Table 2</xref>). Obesity was the smallest trajectory group, but was still composed of 4.4%-7.3% for the study population. The second largest trajectory group was the overweight group, except for women aged 40&#x02013;60, in which low-normal weight was the second largest group.</p><fig position="float" id="pone.0295919.g002"><object-id pub-id-type="doi">10.1371/journal.pone.0295919.g002</object-id><label>Fig 2</label><caption><title>Body mass &#x000cd;ndex traject&#x000f2;ries for the 4-group model over 19 years, adults from MJ cohort, 1998&#x02013;2017.</title><p>Solid Unes ind&#x000ed;cate the mean val&#x000fa;es of body mass &#x000ed;ndex (weight (kg)/height (m)<sup>2</sup>) for members in the groups; dashed lines, 95%confidence intervals, (a) Male aged between 40 and 60. The traject&#x000f2;ries are as follows (from top to bottom): diamond, obesity, increasing; triangle, overweight, increasing; circle, mid-normal weight, increasing; square, low-normal weight, increasing. (b) Male aged over 60. The traject&#x000f2;ries are as follows: diamond, obesity, stable; triangle, overweight, stable; circle, mid-normal weight, stable; square, low-normal weight, stable. (c) Female aged between 40 and 60. The traject&#x000f2;ries are as follows: diamond, obesity, increasing; triangle, overweight, increasing; circle, mid-normal weight, increasing; square, low-normal weight, increasing. (d) Female aged over 60. The traject&#x000f2;ries are as follows: diamond, obesity, increasing; triangle, overweight, stable; circle, mid-normal weight, stable; square, low-normal weight, stable.</p></caption><graphic xlink:href="pone.0295919.g002" position="float"/></fig><table-wrap position="float" id="pone.0295919.t002"><object-id pub-id-type="doi">10.1371/journal.pone.0295919.t002</object-id><label>Table 2</label><caption><title>Estimates of growth curve parameters for body mass index trajectories.</title></caption><alternatives><graphic xlink:href="pone.0295919.t002" id="pone.0295919.t002g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="center" rowspan="2" colspan="1">Male aged over 60</td><td align="center" colspan="2" rowspan="1">Intercept, kg/m<sup>2</sup></td><td align="center" colspan="2" rowspan="1">Linear Slope, kg/m<sup>2</sup></td><td align="center" rowspan="2" colspan="1">Group membership, %</td></tr><tr><td align="center" rowspan="1" colspan="1">Estimate</td><td align="center" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">Estimate</td><td align="center" rowspan="1" colspan="1">95% CI</td></tr><tr><td align="center" rowspan="1" colspan="1">Obesity, stable</td><td align="center" rowspan="1" colspan="1">30.1</td><td align="center" rowspan="1" colspan="1">26.5, 33.7</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">-0.029, 0.031</td><td align="center" rowspan="1" colspan="1">7.3</td></tr><tr><td align="center" rowspan="1" colspan="1">Overweight, stable</td><td align="center" rowspan="1" colspan="1">25.9</td><td align="center" rowspan="1" colspan="1">23.6, 28.2</td><td align="center" rowspan="1" colspan="1">0.01</td><td align="center" rowspan="1" colspan="1">-0.004, 0.023</td><td align="center" rowspan="1" colspan="1">36.1</td></tr><tr><td align="center" rowspan="1" colspan="1">Mid-normal weight, stable</td><td align="center" rowspan="1" colspan="1">22.5</td><td align="center" rowspan="1" colspan="1">20.2, 24.7</td><td align="center" rowspan="1" colspan="1">-0.007</td><td align="center" rowspan="1" colspan="1">-0.02, 0.006</td><td align="center" rowspan="1" colspan="1">42.7</td></tr><tr><td align="center" rowspan="1" colspan="1">Low-normal weight, stable</td><td align="center" rowspan="1" colspan="1">18.8</td><td align="center" rowspan="1" colspan="1">16.2, 21.4</td><td align="center" rowspan="1" colspan="1">0.008</td><td align="center" rowspan="1" colspan="1">-0.016, 0.031</td><td align="center" rowspan="1" colspan="1">13.9</td></tr><tr><td align="center" rowspan="2" colspan="1">Male aged 40&#x02013;60</td><td align="center" colspan="2" rowspan="1">Intercept, kg/m<sup>2</sup></td><td align="center" colspan="2" rowspan="1">Linear Slope, kg/m<sup>2</sup></td><td align="center" rowspan="2" colspan="1">Group membership, %</td></tr><tr><td align="center" rowspan="1" colspan="1">Estimate</td><td align="center" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">Estimate</td><td align="center" rowspan="1" colspan="1">95% CI</td></tr><tr><td align="center" rowspan="1" colspan="1">Obesity, increasing</td><td align="center" rowspan="1" colspan="1">31.1</td><td align="center" rowspan="1" colspan="1">27.1, 35.0</td><td align="center" rowspan="1" colspan="1">0.026</td><td align="center" rowspan="1" colspan="1">0.014, 0.038</td><td align="center" rowspan="1" colspan="1">6.1</td></tr><tr><td align="center" rowspan="1" colspan="1">Overweight, increasing</td><td align="center" rowspan="1" colspan="1">26.7</td><td align="center" rowspan="1" colspan="1">24.4, 29.0</td><td align="center" rowspan="1" colspan="1">0.035</td><td align="center" rowspan="1" colspan="1">0.03, 0.041</td><td align="center" rowspan="1" colspan="1">31.5</td></tr><tr><td align="center" rowspan="1" colspan="1">Mid-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">23.5</td><td align="center" rowspan="1" colspan="1">21.2, 25.7</td><td align="center" rowspan="1" colspan="1">0.025</td><td align="center" rowspan="1" colspan="1">0.021, 0.029</td><td align="center" rowspan="1" colspan="1">46.6</td></tr><tr><td align="center" rowspan="1" colspan="1">Low-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">19.9</td><td align="center" rowspan="1" colspan="1">17.4, 22.5</td><td align="center" rowspan="1" colspan="1">0.031</td><td align="center" rowspan="1" colspan="1">0.024, 0.038</td><td align="center" rowspan="1" colspan="1">15.7</td></tr><tr><td align="center" rowspan="2" colspan="1">Female aged over 60</td><td align="center" colspan="2" rowspan="1">Intercept, kg/m<sup>2</sup></td><td align="center" colspan="2" rowspan="1">Linear Slope, kg/m<sup>2</sup></td><td align="center" rowspan="2" colspan="1">Group membership, %</td></tr><tr><td align="center" rowspan="1" colspan="1">Estimate</td><td align="center" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">Estimate</td><td align="center" rowspan="1" colspan="1">95% CI</td></tr><tr><td align="center" rowspan="1" colspan="1">Obesity, increasing</td><td align="center" rowspan="1" colspan="1">32.7</td><td align="center" rowspan="1" colspan="1">28.4, 36.9</td><td align="center" rowspan="1" colspan="1">0.043</td><td align="center" rowspan="1" colspan="1">0.004, 0.082</td><td align="center" rowspan="1" colspan="1">5.8</td></tr><tr><td align="center" rowspan="1" colspan="1">Overweight, stable</td><td align="center" rowspan="1" colspan="1">27.6</td><td align="center" rowspan="1" colspan="1">24.9, 30.3</td><td align="center" rowspan="1" colspan="1">0.018</td><td align="center" rowspan="1" colspan="1">-0.002, 0.039</td><td align="center" rowspan="1" colspan="1">28.1</td></tr><tr><td align="center" rowspan="1" colspan="1">Mid-normal weight, stable</td><td align="center" rowspan="1" colspan="1">23.7</td><td align="center" rowspan="1" colspan="1">21.2, 26.3</td><td align="center" rowspan="1" colspan="1">0.0002</td><td align="center" rowspan="1" colspan="1">-0.015, 0.016</td><td align="center" rowspan="1" colspan="1">47.2</td></tr><tr><td align="center" rowspan="1" colspan="1">Low-normal weight, stable</td><td align="center" rowspan="1" colspan="1">19.8</td><td align="center" rowspan="1" colspan="1">16.9, 22.8</td><td align="center" rowspan="1" colspan="1">-0.017</td><td align="center" rowspan="1" colspan="1">-0.048, 0.006</td><td align="center" rowspan="1" colspan="1">18.9</td></tr><tr><td align="center" rowspan="2" colspan="1">Female aged 40&#x02013;60</td><td align="center" colspan="2" rowspan="1">Intercept, kg/m<sup>2</sup></td><td align="center" colspan="2" rowspan="1">Linear Slope, kg/m<sup>2</sup></td><td align="center" rowspan="2" colspan="1">Group membership, %</td></tr><tr><td align="center" rowspan="1" colspan="1">Estimate</td><td align="center" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">Estimate</td><td align="center" rowspan="1" colspan="1">95% CI</td></tr><tr><td align="center" rowspan="1" colspan="1">Obesity, increasing</td><td align="center" rowspan="1" colspan="1">32.5</td><td align="center" rowspan="1" colspan="1">27.7, 37.3</td><td align="center" rowspan="1" colspan="1">0.079</td><td align="center" rowspan="1" colspan="1">0.064, 0.095</td><td align="center" rowspan="1" colspan="1">4.4</td></tr><tr><td align="center" rowspan="1" colspan="1">Overweight, increasing</td><td align="center" rowspan="1" colspan="1">27.3</td><td align="center" rowspan="1" colspan="1">24.6, 30.1</td><td align="center" rowspan="1" colspan="1">0.051</td><td align="center" rowspan="1" colspan="1">0.044, 0.058</td><td align="center" rowspan="1" colspan="1">21.9</td></tr><tr><td align="center" rowspan="1" colspan="1">Mid-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">23.6</td><td align="center" rowspan="1" colspan="1">21.2, 25.9</td><td align="center" rowspan="1" colspan="1">0.032</td><td align="center" rowspan="1" colspan="1">0.027, 0.037</td><td align="center" rowspan="1" colspan="1">44</td></tr><tr><td align="center" rowspan="1" colspan="1">Low-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">20.2</td><td align="center" rowspan="1" colspan="1">17.8, 22.7</td><td align="center" rowspan="1" colspan="1">0.012</td><td align="center" rowspan="1" colspan="1">0.007, 0.018</td><td align="center" rowspan="1" colspan="1">29.7</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Abbreviations: CI, confidence interval.</p></fn></table-wrap-foot></table-wrap><p>Body mass index trajectories for the 4-group model over 19 years, adults from MJ cohort, 1998&#x02013;2017. Solid lines indicate the mean values of body mass index (weight (kg)/height (m)<sup>2</sup>) for members in the groups; dashed lines, 95% confidence intervals. (a) Male aged between 40 and 60. The trajectories are as follows (from top to bottom): diamond, obesity, increasing; triangle, overweight, increasing; circle, mid-normal weight, increasing; square, low-normal weight, increasing. (b) Male aged over 60. The trajectories are as follows: diamond, obesity, stable; triangle, overweight, stable; circle, mid-normal weight, stable; square, low-normal weight, stable. (c) Female aged between 40 and 60. The trajectories are as follows: diamond, obesity, increasing; triangle, overweight, increasing; circle, mid-normal weight, increasing; square, low-normal weight, increasing. (d) Female aged over 60. The trajectories are as follows: diamond, obesity, increasing; triangle, overweight, stable; circle, mid-normal weight, stable; square, low-normal weight, stable.</p><p>HRs for overall mortality are displayed in <xref rid="pone.0295919.t003" ref-type="table">Table 3</xref> using the &#x0201c;mid-normal weight&#x0201d; trajectory group as the referent. Model 1 represents the model without any adjustment, whereas model 2 is fully adjusted for age, educational level, smoking status, alcohol consumption, and physical activity. Regardless of age and sex, the obesity group has the highest adjusted HR (men aged over 60: aHR = 1.26(CI = 1.12&#x02013;1.42); men aged 40&#x02013;60: aHR = 1.40(CI = 1.24&#x02013;1.58); women aged over 60: aHR = 1.24(CI = 1.06&#x02013;1.45); women aged 40&#x02013;60: aHR = 1.33[CI = 1.14&#x02013;1.57]). For men aged over 60, overweight is a protective factor in the unadjusted model (HR = 0.93, 95%CI = 0.87&#x02013;0.99), but the effect disappeared after adjusting for lifestyle factors, age and education. Low-normal weight was significantly associated with mortality for all age and sex groups, except for women aged 40&#x02013;60.</p><table-wrap position="float" id="pone.0295919.t003"><object-id pub-id-type="doi">10.1371/journal.pone.0295919.t003</object-id><label>Table 3</label><caption><title>Association between body mass index trajectories and all-cause mortality.</title></caption><alternatives><graphic xlink:href="pone.0295919.t003" id="pone.0295919.t003g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="center" rowspan="2" colspan="1">Male aged over 60</td><td align="center" rowspan="2" colspan="1">Death, number of death/ number of participants %</td><td align="center" colspan="2" rowspan="1">Model 1<xref rid="t003fn005" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" colspan="2" rowspan="1">Model 2<xref rid="t003fn006" ref-type="table-fn"><sup>b</sup></xref></td></tr><tr><td align="center" rowspan="1" colspan="1">HR</td><td align="center" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">HR</td><td align="center" rowspan="1" colspan="1">95% CI</td></tr><tr><td align="center" rowspan="1" colspan="1">Obesity, stable</td><td align="center" rowspan="1" colspan="1">324/549, 59%</td><td align="center" rowspan="1" colspan="1">1.14<xref rid="t003fn002" ref-type="table-fn">*</xref></td><td align="center" rowspan="1" colspan="1">1.01, 1.28</td><td align="center" rowspan="1" colspan="1">1.26<xref rid="t003fn004" ref-type="table-fn">***</xref></td><td align="center" rowspan="1" colspan="1">1.12, 1.42</td></tr><tr><td align="center" rowspan="1" colspan="1">Overweight, stable</td><td align="center" rowspan="1" colspan="1">1544/2958, 52%</td><td align="center" rowspan="1" colspan="1">0.93<xref rid="t003fn002" ref-type="table-fn">*</xref></td><td align="center" rowspan="1" colspan="1">0.87, 0.99</td><td align="center" rowspan="1" colspan="1">0.98</td><td align="center" rowspan="1" colspan="1">0.91, 1.04</td></tr><tr><td align="center" rowspan="1" colspan="1">Mid-normal weight, stable</td><td align="center" rowspan="1" colspan="1">1947/3582, 54%</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">referent</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">referent</td></tr><tr><td align="center" rowspan="1" colspan="1">low-normal weight, stable</td><td align="center" rowspan="1" colspan="1">683/1057, 65%</td><td align="center" rowspan="1" colspan="1">1.31<xref rid="t003fn004" ref-type="table-fn">***</xref></td><td align="center" rowspan="1" colspan="1">1.20, 1.43</td><td align="center" rowspan="1" colspan="1">1.21<xref rid="t003fn004" ref-type="table-fn">***</xref></td><td align="center" rowspan="1" colspan="1">1.11, 1.32</td></tr><tr><td align="center" rowspan="2" colspan="1">Male aged 40&#x02013;60</td><td align="center" rowspan="2" colspan="1">Death, number of death/ number of participants %</td><td align="center" colspan="2" rowspan="1">Model 1<xref rid="t003fn005" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" colspan="2" rowspan="1">Model 2<xref rid="t003fn006" ref-type="table-fn"><sup>b</sup></xref></td></tr><tr><td align="center" rowspan="1" colspan="1">HR</td><td align="center" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">HR</td><td align="center" rowspan="1" colspan="1">95% CI</td></tr><tr><td align="center" rowspan="1" colspan="1">Obesity, increasing</td><td align="center" rowspan="1" colspan="1">298/1983, 15%</td><td align="center" rowspan="1" colspan="1">1.46<xref rid="t003fn004" ref-type="table-fn">***</xref></td><td align="center" rowspan="1" colspan="1">1.29, 1.65</td><td align="center" rowspan="1" colspan="1">1.40<xref rid="t003fn004" ref-type="table-fn">***</xref></td><td align="center" rowspan="1" colspan="1">1.24, 1.58</td></tr><tr><td align="center" rowspan="1" colspan="1">Overweight, increasing</td><td align="center" rowspan="1" colspan="1">1255/10557, 12%</td><td align="center" rowspan="1" colspan="1">1.11<xref rid="t003fn003" ref-type="table-fn">**</xref></td><td align="center" rowspan="1" colspan="1">1.03, 1.20</td><td align="center" rowspan="1" colspan="1">1.11<xref rid="t003fn003" ref-type="table-fn">**</xref></td><td align="center" rowspan="1" colspan="1">1.04, 1.20</td></tr><tr><td align="center" rowspan="1" colspan="1">Mid-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">1754/10357, 17%</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">referent</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">referent</td></tr><tr><td align="center" rowspan="1" colspan="1">low-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">680/4943, 14%</td><td align="center" rowspan="1" colspan="1">1.30<xref rid="t003fn004" ref-type="table-fn">***</xref></td><td align="center" rowspan="1" colspan="1">1.19, 1.42</td><td align="center" rowspan="1" colspan="1">1.21<xref rid="t003fn004" ref-type="table-fn">***</xref></td><td align="center" rowspan="1" colspan="1">1.11, 1.32</td></tr><tr><td align="center" rowspan="2" colspan="1">Female aged over 60</td><td align="center" rowspan="2" colspan="1">Death, number of death/ number of participants %</td><td align="center" colspan="2" rowspan="1">Model 1<xref rid="t003fn005" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" colspan="2" rowspan="1">Model 2<xref rid="t003fn006" ref-type="table-fn"><sup>b</sup></xref></td></tr><tr><td align="center" rowspan="1" colspan="1">HR</td><td align="center" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">HR</td><td align="center" rowspan="1" colspan="1">95% CI</td></tr><tr><td align="center" rowspan="1" colspan="1">Obesity, stable</td><td align="center" rowspan="1" colspan="1">180/417, 43%</td><td align="center" rowspan="1" colspan="1">1.16</td><td align="center" rowspan="1" colspan="1">0.99, 1.35</td><td align="center" rowspan="1" colspan="1">1.24<xref rid="t003fn003" ref-type="table-fn">**</xref></td><td align="center" rowspan="1" colspan="1">1.06, 1.45</td></tr><tr><td align="center" rowspan="1" colspan="1">Overweight, stable</td><td align="center" rowspan="1" colspan="1">867/2089, 42%</td><td align="center" rowspan="1" colspan="1">1.10<xref rid="t003fn003" ref-type="table-fn">**</xref></td><td align="center" rowspan="1" colspan="1">1.01, 1.20</td><td align="center" rowspan="1" colspan="1">1.02</td><td align="center" rowspan="1" colspan="1">0.93, 1.11</td></tr><tr><td align="center" rowspan="1" colspan="1">Mid-normal weight, stable</td><td align="center" rowspan="1" colspan="1">1455/3785, 38%</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">referent</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">referent</td></tr><tr><td align="center" rowspan="1" colspan="1">Low-normal weight, decreasing</td><td align="center" rowspan="1" colspan="1">598/1330, 45%</td><td align="center" rowspan="1" colspan="1">1.24<xref rid="t003fn004" ref-type="table-fn">***</xref></td><td align="center" rowspan="1" colspan="1">1.13, 1.37</td><td align="center" rowspan="1" colspan="1">1.15<xref rid="t003fn003" ref-type="table-fn">**</xref></td><td align="center" rowspan="1" colspan="1">1.04, 1.26</td></tr><tr><td align="center" rowspan="2" colspan="1">Female aged 40&#x02013;60</td><td align="center" rowspan="2" colspan="1">Death, number of death/ number of participants %</td><td align="center" colspan="2" rowspan="1">Model 1<xref rid="t003fn005" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" colspan="2" rowspan="1">Model 2<xref rid="t003fn006" ref-type="table-fn"><sup>b</sup></xref></td></tr><tr><td align="center" rowspan="1" colspan="1">HR</td><td align="center" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">HR</td><td align="center" rowspan="1" colspan="1">95% CI</td></tr><tr><td align="center" rowspan="1" colspan="1">Obesity, increasing</td><td align="center" rowspan="1" colspan="1">170/1710, 10%</td><td align="center" rowspan="1" colspan="1">1.53<xref rid="t003fn004" ref-type="table-fn">***</xref></td><td align="center" rowspan="1" colspan="1">1.30, 1.80</td><td align="center" rowspan="1" colspan="1">1.33<xref rid="t003fn003" ref-type="table-fn">**</xref></td><td align="center" rowspan="1" colspan="1">1.14, 1.57</td></tr><tr><td align="center" rowspan="1" colspan="1">Overweight, increasing</td><td align="center" rowspan="1" colspan="1">760/8641, 9%</td><td align="center" rowspan="1" colspan="1">1.32<xref rid="t003fn004" ref-type="table-fn">***</xref></td><td align="center" rowspan="1" colspan="1">1.21, 1.45</td><td align="center" rowspan="1" colspan="1">1.16<xref rid="t003fn003" ref-type="table-fn">**</xref></td><td align="center" rowspan="1" colspan="1">1.06, 1.27</td></tr><tr><td align="center" rowspan="1" colspan="1">Mid-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">1232/18273, 7%</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">referent</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">referent</td></tr><tr><td align="center" rowspan="1" colspan="1">Low-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">701/11711, 6%</td><td align="center" rowspan="1" colspan="1">0.88<xref rid="t003fn003" ref-type="table-fn">**</xref></td><td align="center" rowspan="1" colspan="1">0.80, 0.96</td><td align="center" rowspan="1" colspan="1">1.05</td><td align="center" rowspan="1" colspan="1">0.96, 1.15</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Abbreviations: CI, confidence interval; HR, Hazard ratio.</p></fn><fn id="t003fn002"><p>*p&#x0003c;0.05,</p></fn><fn id="t003fn003"><p>**p&#x0003c;0.01,</p></fn><fn id="t003fn004"><p>***p&#x0003c;0.0001.</p></fn><fn id="t003fn005"><p><sup>a</sup> Unadjusted model.</p></fn><fn id="t003fn006"><p><sup>b</sup> Fully adjusted model: adjusted for age, education level, smoking status, alcohol consumption and physical activity.</p></fn></table-wrap-foot></table-wrap><p>We conducted cause-specific analysis for competing risk analysis; the aHR are shown in <xref rid="pone.0295919.t004" ref-type="table">Table 4</xref> with a fully adjusted model. Likewise, the &#x0201c;mid-normal weight&#x0201d; trajectory was treated as the referent for each age and sex groups. Regardless of age and sex, respiratory disease had a significantly increasing mortality risk in low-normal weight groups (men aged over 60: aHR = 1.70(CI = 1.39&#x02013;2.08); men aged 40&#x02013;60: aHR = 1.85(CI = 1.31&#x02013;2.61); women aged over 60: aHR = 1.94(CI = 1.45&#x02013;2.58); women aged 40&#x02013;60: aHR = 1.74(CI = 1.10&#x02013;2.74)). In addition, a significantly increasing risk of mortality of cardiovascular disease in the obesity trajectory group was also found in all age and sex groups (men aged over 60: aHR = 1.34(CI = 1.06&#x02013;1.69); men aged 40&#x02013;60: aHR = 2.08(CI = 1.61&#x02013;2.68); women aged over 60: aHR = 1.35(CI = 1.02&#x02013;1.81); women aged 40&#x02013;60: aHR = 1.62(CI = 1.09&#x02013;2.41)).</p><table-wrap position="float" id="pone.0295919.t004"><object-id pub-id-type="doi">10.1371/journal.pone.0295919.t004</object-id><label>Table 4</label><caption><title>Association between body mass index trajectories and cause-specific mortality hazard ratio<xref rid="t004fn001" ref-type="table-fn"><sup>a</sup></xref>.</title></caption><alternatives><graphic xlink:href="pone.0295919.t004" id="pone.0295919.t004g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="center" rowspan="1" colspan="1">Male aged over 60</td><td align="center" rowspan="1" colspan="1">low-normal weight, stable</td><td align="center" rowspan="1" colspan="1">Mid-normal weight, stable</td><td align="center" rowspan="1" colspan="1">Overweight, stable</td><td align="center" rowspan="1" colspan="1">Obesity, stable</td></tr><tr><td align="center" rowspan="1" colspan="1">Cancer</td><td align="center" rowspan="1" colspan="1">1.06 (0.90, 1.25)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.01 (0.89, 1.13)</td><td align="center" rowspan="1" colspan="1">1.336<xref rid="t004fn004" ref-type="table-fn">***</xref> (1.09, 1.64)</td></tr><tr><td align="center" rowspan="1" colspan="1">Cardiovascular disease</td><td align="center" rowspan="1" colspan="1">0.94 (0.77, 1.15)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.994 (0.87, 1.14)</td><td align="center" rowspan="1" colspan="1">1.336<xref rid="t004fn004" ref-type="table-fn">***</xref> (1.06, 1.69)</td></tr><tr><td align="center" rowspan="1" colspan="1">Respiratory disease</td><td align="center" rowspan="1" colspan="1">1.70<xref rid="t004fn004" ref-type="table-fn">***</xref> (1.39, 2.08)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.817<xref rid="t004fn003" ref-type="table-fn">**</xref> (0.68, 0.98)</td><td align="center" rowspan="1" colspan="1">1.027 (0.73, 1.46)</td></tr><tr><td align="center" rowspan="1" colspan="1">Others</td><td align="center" rowspan="1" colspan="1">1.33<xref rid="t004fn003" ref-type="table-fn">**</xref> (1.14, 1.55)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.004 (0.89, 1.13)</td><td align="center" rowspan="1" colspan="1">1.232 (0.99, 1.53)</td></tr><tr><td align="center" rowspan="1" colspan="1">Male aged 40&#x02013;60</td><td align="center" rowspan="1" colspan="1">low-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">Mid-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">Overweight, increasing</td><td align="center" rowspan="1" colspan="1">Obesity, increasing</td></tr><tr><td align="center" rowspan="1" colspan="1">Cancer</td><td align="center" rowspan="1" colspan="1">1.02 (0.92, 1.30)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.061 (0.95, 1.18)</td><td align="center" rowspan="1" colspan="1">1.205 (0.99, 1.46)</td></tr><tr><td align="center" rowspan="1" colspan="1">Cardiovascular disease</td><td align="center" rowspan="1" colspan="1">1.12 (0.90, 1.40)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.363<xref rid="t004fn003" ref-type="table-fn">**</xref> (1.16, 1.61)</td><td align="center" rowspan="1" colspan="1">2.079<xref rid="t004fn004" ref-type="table-fn">***</xref> (1.61, 2.68)</td></tr><tr><td align="center" rowspan="1" colspan="1">Respiratory disease</td><td align="center" rowspan="1" colspan="1">1.85<xref rid="t004fn004" ref-type="table-fn">***</xref> (1.31, 2.61)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.002 (0.71, 1.41)</td><td align="center" rowspan="1" colspan="1">0.699 (0.32, 1.51)</td></tr><tr><td align="center" rowspan="1" colspan="1">Others</td><td align="center" rowspan="1" colspan="1">1.25<xref rid="t004fn003" ref-type="table-fn">**</xref> (1.07, 1.46)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.07 (0.94, 1.22)</td><td align="center" rowspan="1" colspan="1">1.425<xref rid="t004fn003" ref-type="table-fn">**</xref> (1.15, 1.77)</td></tr><tr><td align="center" rowspan="1" colspan="1">Female aged over 60</td><td align="center" rowspan="1" colspan="1">low-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">Mid-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">Overweight, increasing</td><td align="center" rowspan="1" colspan="1">Obesity, increasing</td></tr><tr><td align="center" rowspan="1" colspan="1">Cancer</td><td align="center" rowspan="1" colspan="1">0.92 (0.75, 1.12)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.01 (0.86, 1.19)</td><td align="center" rowspan="1" colspan="1">0.75<xref rid="t004fn004" ref-type="table-fn">***</xref> (0.60, 0.93)</td></tr><tr><td align="center" rowspan="1" colspan="1">Cardiovascular disease</td><td align="center" rowspan="1" colspan="1">1.08 (0.89, 1.31)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.10 (0.96, 1.22)</td><td align="center" rowspan="1" colspan="1">1.35<xref rid="t004fn002" ref-type="table-fn">*</xref> (1.02, 1.81)</td></tr><tr><td align="center" rowspan="1" colspan="1">Respiratory disease</td><td align="center" rowspan="1" colspan="1">1.94<xref rid="t004fn004" ref-type="table-fn">***</xref> (1.45, 2.58)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.19 (0.94, 1.21)</td><td align="center" rowspan="1" colspan="1">1.24 (0.70, 2.22)</td></tr><tr><td align="center" rowspan="1" colspan="1">Others</td><td align="center" rowspan="1" colspan="1">1.21<xref rid="t004fn002" ref-type="table-fn">*</xref> (1.04, 1.40)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.10 (0.95, 1.26)</td><td align="center" rowspan="1" colspan="1">1.56<xref rid="t004fn003" ref-type="table-fn">**</xref> (1.24, 1.96)</td></tr><tr><td align="center" rowspan="1" colspan="1">Female aged 40&#x02013;60</td><td align="center" rowspan="1" colspan="1">low-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">Mid-normal weight, increasing</td><td align="center" rowspan="1" colspan="1">Overweight, increasing</td><td align="center" rowspan="1" colspan="1">Obesity, increasing</td></tr><tr><td align="center" rowspan="1" colspan="1">Cancer</td><td align="center" rowspan="1" colspan="1">0.96 (0.84, 1.09)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.04 (0.91, 1.18)</td><td align="center" rowspan="1" colspan="1">1.02 (0.79, 1.32)</td></tr><tr><td align="center" rowspan="1" colspan="1">Cardiovascular disease</td><td align="center" rowspan="1" colspan="1">1.15 (0.90, 1.48)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.50<xref rid="t004fn003" ref-type="table-fn">**</xref> (1.19, 1.88)</td><td align="center" rowspan="1" colspan="1">1.62<xref rid="t004fn002" ref-type="table-fn">*</xref> (1.09, 2.41)</td></tr><tr><td align="center" rowspan="1" colspan="1">Respiratory disease</td><td align="center" rowspan="1" colspan="1">1.74<xref rid="t004fn004" ref-type="table-fn">***</xref> (1.10, 2.74)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.11 (0.68, 1.82)</td><td align="center" rowspan="1" colspan="1">2.03 (0.98, 4.19)</td></tr><tr><td align="center" rowspan="1" colspan="1">Others</td><td align="center" rowspan="1" colspan="1">1.09 (0.92, 1.30)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.23<xref rid="t004fn002" ref-type="table-fn">*</xref> (1.04, 1.45)</td><td align="center" rowspan="1" colspan="1">1.68<xref rid="t004fn003" ref-type="table-fn">**</xref> (1.29, 2.19)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p><sup>a</sup>: Fully adjusted model: Adjusted for age, education level, smoking status, alcohol consumption and physical activity.</p></fn><fn id="t004fn002"><p>*p&#x0003c;0.05,</p></fn><fn id="t004fn003"><p>**p&#x0003c;0.01,</p></fn><fn id="t004fn004"><p>***p&#x0003c;0.0001.</p></fn></table-wrap-foot></table-wrap><p>The obesity trajectory group had contrary mortality risk of cancer disease comparing men and women aged over 60. For men, the &#x0201c;obesity, stable&#x0201d; group had higher cancer mortality risk (aHR = 1.34, 95% CI = 1.09, 1.64), but for women, the &#x0201c;obesity, decreasing&#x0201d; group had a decreased risk compared to the referent (aHR = 0.75, CI = 0.60, 0.93).</p></sec><sec sec-type="conclusions" id="sec009"><title>Discussion</title><p>The present study identified BMI trajectories over 18 years in a large sample of adults older than 40 years of age and examined the association of various BMI trajectory groups with all-cause and cause-specific mortality risk. This is one of the largest studies with almost twenty years of follow-up to examine the grouping of BMI changes in adulthood objectively and repeatedly.</p><p>There are several key findings in our study. First, we identified four distinct BMI trajectory groups for all gender and age combinations: low-normal weight, mid-normal weight, overweight, and obesity. Second, CVD-related mortality was associated with overweight and obese trajectory in middle-aged men and women, but not in older age men and women. Third, obesity was a protective factor in cancer-related mortality in women but a risk factor in men aged over 60. Fourth, low-normal weight was a risk factor in respiratory-related mortality for all age and gender groups.</p><p>The distribution of populations in different trajectory groups and the change of pattern of trajectory groups over time in Taiwan are different from Western populations. Our study&#x02019;s main advantage is the objective and repeated measurements of weight at various points in time. This allowed us to determine BMI trajectories throughout adulthood and to categorize BMI into distinct groups over time.</p><p>There are some major differences comparing the BMI trajectory in our sample and in Western populations. First, the majority of the population concentrates in the mid-normal weight group in Taiwan, whereas in Western populations, such as in the US, trajectories of overweight and obesity often account for 70%&#x02013;80% of the sample [<xref rid="pone.0295919.ref028" ref-type="bibr">28</xref>&#x02013;<xref rid="pone.0295919.ref030" ref-type="bibr">30</xref>]. Our data are similar to other Asian countries such as Japan [<xref rid="pone.0295919.ref005" ref-type="bibr">5</xref>], where the mid-normal weight group is composed of 67.1% of the population. Second, the body weight status does not seem to vary across the lifetime in our sample, which is similar to studies in Japan [<xref rid="pone.0295919.ref005" ref-type="bibr">5</xref>], but different in studies in the US and Austria [<xref rid="pone.0295919.ref029" ref-type="bibr">29</xref>&#x02013;<xref rid="pone.0295919.ref031" ref-type="bibr">31</xref>]. Asian populations may be different from Western populations on the issue of BMI trajectory. Third, we showed an increasing pattern of groups aged between 40 and 60, which was not demonstrated in other studies because most of the studies that examined the BMI trajectory and mortality only used data from older adults, such as aged over 60 [<xref rid="pone.0295919.ref028" ref-type="bibr">28</xref>].</p><p>The result of all-cause mortality among the older population in our study is compatible with a study in Japan that showed the lowest mortality risk in normal and the overweight trajectory group [<xref rid="pone.0295919.ref005" ref-type="bibr">5</xref>]. Older populations tend to have a reverse J-shaped association of BMI with all-cause mortality, indicating that underweight and obesity are both important risk factor of mortality, as shown in US, Canada and Australia [<xref rid="pone.0295919.ref032" ref-type="bibr">32</xref>&#x02013;<xref rid="pone.0295919.ref034" ref-type="bibr">34</xref>]. This so-called &#x0201c;obesity paradox,&#x0201d; that a higher BMI has protective association with all-cause mortality in older population [<xref rid="pone.0295919.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0295919.ref035" ref-type="bibr">35</xref>], was also found in our sample of the Taiwanese population. Combining the finding of obesity as not being a protective factor for mid-aged adults in our sample, one possible mechanism may have been selection bias. Obese mid-aged adults might be more likely to die from CVD death if they have severe obesity-related CVD. This may result in a sample biased toward less risk of obesity-associated CVD death in older population. Our analysis also confirmed an association between CVD deaths and obesity in mid-aged adults.</p><p>In the present study, obesity was a protective factor in cancer-related mortality in women but not in men. Sex differences might occur due to the four following reasons:</p><p>(1) Estrogens could inhibit the growth of tumor, such as for esophageal cancer [<xref rid="pone.0295919.ref036" ref-type="bibr">36</xref>], liver cancer [<xref rid="pone.0295919.ref037" ref-type="bibr">37</xref>,<xref rid="pone.0295919.ref038" ref-type="bibr">38</xref>], and colon cancer [<xref rid="pone.0295919.ref039" ref-type="bibr">39</xref>,<xref rid="pone.0295919.ref040" ref-type="bibr">40</xref>]. Cancer cell progression rate is associated with sex hormones and with the altered hormone environment in an obese state [<xref rid="pone.0295919.ref041" ref-type="bibr">41</xref>]. After menopause, the level of estrogen decreases in women with normal weight; however, in overweight or obese woman, the adipose tissue can secret estrogen. The level of estrogen is significantly higher in postmenopausal obese women than in postmenopausal normal-weight women, and is also higher than in men [<xref rid="pone.0295919.ref042" ref-type="bibr">42</xref>], and may in turn protect obese older women from cancer.</p><p>(2) Sex-related differences at the genetic and molecular levels can affect the differences in the degree of response to chemotherapy [<xref rid="pone.0295919.ref043" ref-type="bibr">43</xref>,<xref rid="pone.0295919.ref044" ref-type="bibr">44</xref>]. Several commonly used chemotherapy agents, such as 5-fluorouracil, doxorubicin, cisplatin, and paclitaxel, all have a lower clearance rate in women, which leads to higher therapeutic efficacy but also to more severe toxicity [<xref rid="pone.0295919.ref045" ref-type="bibr">45</xref>], such as lung cancer [<xref rid="pone.0295919.ref044" ref-type="bibr">44</xref>,<xref rid="pone.0295919.ref046" ref-type="bibr">46</xref>], colon cancer [<xref rid="pone.0295919.ref044" ref-type="bibr">44</xref>], gastric and pancreatic cancers [<xref rid="pone.0295919.ref044" ref-type="bibr">44</xref>]. Sex differences in cancer-related mortality may result from better prognosis of cancer treatment in obese women.</p><p>In the present study, low-normal weight was a risk factor in respiratory-related mortality in all four groups. Several studies expressed similar results, such as in Spain, Finland, and New Zealand [<xref rid="pone.0295919.ref047" ref-type="bibr">47</xref>&#x02013;<xref rid="pone.0295919.ref049" ref-type="bibr">49</xref>]. A meta-analysis found that, compared to normal BMI, underweight adults with COPD have an increased risk of mortality [<xref rid="pone.0295919.ref050" ref-type="bibr">50</xref>]. This is because lower BMI is associated with an accelerated lung function decline in adults, resulting in higher livelihood for COPD [<xref rid="pone.0295919.ref050" ref-type="bibr">50</xref>], and for other respiratory diseases as well, such as cystic fibrosis, asthma, and pneumonia [<xref rid="pone.0295919.ref051" ref-type="bibr">51</xref>,<xref rid="pone.0295919.ref052" ref-type="bibr">52</xref>]. A possible explanation is that reduced skeletal muscle mass&#x02014;especially reduced diaphragmatic muscle mass&#x02014;is associated with low pulmonary function because of the decreased strength of the respiratory muscles [<xref rid="pone.0295919.ref053" ref-type="bibr">53</xref>]. In a study of healthy adults in Korea [<xref rid="pone.0295919.ref054" ref-type="bibr">54</xref>], the parameter which represented pulmonary function&#x02014;forced expiratory volume (FEV1)&#x02014;was decreased in an underweight population compared to normal weight (Odds Ratio (OR) = 2.10, 95% CI = 1.98&#x02013;2.21). Underweight adults who are at risk for respiratory diseases may consider pulmonary rehabilitation programs that aim to improve lung function in addition to increasing weight [<xref rid="pone.0295919.ref054" ref-type="bibr">54</xref>]. Another explanation is that genetic factors modulate both BMI and lung function. For example, several studies, such as in US, Norway and Iran, found a significant association between BMI and the fat mass and obesity-associated (FTO) genes in many general population studies [<xref rid="pone.0295919.ref055" ref-type="bibr">55</xref>,<xref rid="pone.0295919.ref056" ref-type="bibr">56</xref>]. Among the FTO genes, the rs8050136 minor allele was associated with both higher BMI and better lung function [<xref rid="pone.0295919.ref057" ref-type="bibr">57</xref>].</p><p>The present study has several limitations. First, the time between the measurements was 3 years, limiting information regarding changes in between. However, in our results, there is limited change of BMI over each three years; we do not think this limitation will affect our results regarding trajectory analysis. Second, although BMI is the most commonly used measure of adiposity, it has been criticized as not being able to distinguish between excess fat, muscle, water, or bone mass [<xref rid="pone.0295919.ref058" ref-type="bibr">58</xref>], nor does it provide any indication of the distribution of fat among individuals, such as visceral fat or cutaneous fat [<xref rid="pone.0295919.ref058" ref-type="bibr">58</xref>]. This may lead to misclassification bias. The term of normal weight obesity (NWO) has been used since 2008, whereas around 15% of people were classified as NWO [<xref rid="pone.0295919.ref059" ref-type="bibr">59</xref>]. However, this relatively small percentage population may not lead to severe bias since some studies, which pay attention to the representativeness of BMI to obesity, still announce that BMI is still a good index for cardio-metabolic risk [<xref rid="pone.0295919.ref060" ref-type="bibr">60</xref>]. However, it is still important for further research to focus on the representativeness of BMI to obesity.</p><p>(3) Our dataset did not measure some confounders that are associated with both BMI trajectory and certain causes of death, such as common genetic factors, such as FTO genes and comorbidities such as diabetes, hypertension, liver and kidney diseases that were not available in the analysis.</p><p>The effect of causal inference cannot be fully established. The literature on BMI trajectory and all-cause mortality, such as studies from Australia and Japan, have adjusted for confounders including diabetes and heart disease [<xref rid="pone.0295919.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0295919.ref030" ref-type="bibr">30</xref>]. When comparing the results between unadjusted and adjusted, the result of all-cause specific mortality was generally similar [<xref rid="pone.0295919.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0295919.ref030" ref-type="bibr">30</xref>]. Some of the roles of potential confounders such as diabetes might become mediators in a longitudinal study because people who are obese might also develop diabetes later on even if they do not have diabetes in the baseline. How these potential confounders might complicate the association between a longitudinal trajectory and mortality would require further analysis. Our study can offer an exploratory analysis only on the association, and warrants caution when interpreting our findings.</p><p>(4) Because the participation of MJ health screening is membership based, it is possible that this cohort may have had a slightly higher socioeconomic status than in the general Taiwanese population [<xref rid="pone.0295919.ref022" ref-type="bibr">22</xref>]. Our study population had a higher mean age in the group of 40&#x02013;60 (55.2-year-old versus 47.2-year-old) compared to the whole Taiwanese population at year 2000 (the year of recruitment), but was similar in the group of 60+ (69.8-year-old versus 70-year-old). The findings of our study are not generalizable to the Taiwanese population.</p><p>In conclusion, our study highlighted the impact of the BMI trajectory on cause-specific mortality. In contrast to prior observations made regarding Western populations, BMI change over time remain unchanged in nearly all trajectory groups. In our research, both the low-normal weight and obese group had significantly higher mortality risk compared to the mid-normal weight group in adults aged 40 to 60 among both sexes; this indicates that no obesity paradox was found in this age group. In cause-specific mortality risk, low-normal weight is always related to high risk of respiratory disease-related death, whereas obesity seems to be a protective factor to cancer-related mortality risk in women aged over 60 but not in men. Our research suggests that, in mid-life, it still shows benefit to maintain a mid-normal weight in order to lower the mortality risk, whereas an intervention of a pulmonary rehabilitation program should be performed for low-normal weight groups. These findings could provide both clinical and public health approaches to body-weight management conducive to improving the survival of adults both in their mid- or late lives&#x02014;particularly in Asian populations.</p></sec></body><back><ack><p>We are grateful to the study participants.</p></ack><ref-list><title>References</title><ref id="pone.0295919.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Ye</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Pan</surname><given-names>XF</given-names></name>, <name><surname>Pan</surname><given-names>A</given-names></name>. <article-title>Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study</article-title>. <source>Bmj</source>. <year>2019</year>;<volume>367</volume>:<fpage>l5584</fpage>. Epub 2019/10/18. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.l5584</pub-id> .<pub-id pub-id-type="pmid">31619383</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>H</given-names></name>, <name><surname>Tumin</surname><given-names>D</given-names></name>, <name><surname>Qian</surname><given-names>Z</given-names></name>. <article-title>Obesity and mortality risk: new findings from body mass index trajectories</article-title>. <source>Am J Epidemiol</source>. <year>2013</year>;<volume>178</volume>(<issue>11</issue>):<fpage>1591</fpage>&#x02013;<lpage>9</lpage>. Epub 2013/09/10. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwt179</pub-id> .<pub-id pub-id-type="pmid">24013201</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Suzuki</surname><given-names>S</given-names></name>, <name><surname>Kojima</surname><given-names>M</given-names></name>, <name><surname>Tokudome</surname><given-names>S</given-names></name>, <name><surname>Mori</surname><given-names>M</given-names></name>, <name><surname>Sakauchi</surname><given-names>F</given-names></name>, <name><surname>Wakai</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Obesity/weight gain and breast cancer risk: findings from the Japan collaborative cohort study for the evaluation of cancer risk</article-title>. <source>J Epidemiol</source>. <year>2013</year>;<volume>23</volume>(<issue>2</issue>):<fpage>139</fpage>&#x02013;<lpage>45</lpage>. Epub 2013/02/27. <comment>doi: </comment><pub-id pub-id-type="doi">10.2188/jea.je20120102</pub-id> .<pub-id pub-id-type="pmid">23438695</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Kong</surname><given-names>KA</given-names></name>, <name><surname>Park</surname><given-names>J</given-names></name>, <name><surname>Hong</surname><given-names>SH</given-names></name>, <name><surname>Hong</surname><given-names>YS</given-names></name>, <name><surname>Sung</surname><given-names>YA</given-names></name>, <name><surname>Lee</surname><given-names>H</given-names></name>. <article-title>Associations between body mass index and mortality or cardiovascular events in a general Korean population</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>9</issue>):<fpage>e0185024</fpage>. Epub 2017/09/16. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0185024</pub-id> .<pub-id pub-id-type="pmid">28915262</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Murayama</surname><given-names>H</given-names></name>, <name><surname>Liang</surname><given-names>J</given-names></name>, <name><surname>Bennett</surname><given-names>JM</given-names></name>, <name><surname>Shaw</surname><given-names>BA</given-names></name>, <name><surname>Botoseneanu</surname><given-names>A</given-names></name>, <name><surname>Kobayashi</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Trajectories of Body Mass Index and Their Associations With Mortality Among Older Japanese: Do They Differ From Those of Western Populations?</article-title>
<source>Am J Epidemiol</source>. <year>2015</year>;<volume>182</volume>(<issue>7</issue>):<fpage>597</fpage>&#x02013;<lpage>605</lpage>. Epub 2015/09/13. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwv107</pub-id> .<pub-id pub-id-type="pmid">26363514</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Strandberg</surname><given-names>TE</given-names></name>, <name><surname>Strandberg</surname><given-names>AY</given-names></name>, <name><surname>Salomaa</surname><given-names>VV</given-names></name>, <name><surname>Pitk&#x000e4;l&#x000e4;</surname><given-names>KH</given-names></name>, <name><surname>Tilvis</surname><given-names>RS</given-names></name>, <name><surname>Sirola</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men</article-title>. <source>Eur Heart J</source>. <year>2009</year>;<volume>30</volume>(<issue>14</issue>):<fpage>1720</fpage>&#x02013;<lpage>7</lpage>. Epub 2009/05/12. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/eurheartj/ehp162</pub-id> .<pub-id pub-id-type="pmid">19429917</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Hainer</surname><given-names>V</given-names></name>, <name><surname>Aldhoon-Hainerov&#x000e1;</surname><given-names>I</given-names></name>. <article-title>Obesity paradox does exist</article-title>. <source>Diabetes Care</source>. <year>2013</year>;<volume>36</volume>
<issue>Suppl 2</issue>(Suppl 2):<fpage>S276</fpage>&#x02013;<lpage>81</lpage>. Epub 2013/08/02. <comment>doi: </comment><pub-id pub-id-type="doi">10.2337/dcS13-2023</pub-id> .<pub-id pub-id-type="pmid">23882059</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Banack</surname><given-names>HR</given-names></name>, <name><surname>Kaufman</surname><given-names>JS</given-names></name>. <article-title>The obesity paradox: understanding the effect of obesity on mortality among individuals with cardiovascular disease</article-title>. <source>Prev Med</source>. <year>2014</year>;<volume>62</volume>:<fpage>96</fpage>&#x02013;<lpage>102</lpage>. Epub 2014/02/15. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ypmed.2014.02.003</pub-id> .<pub-id pub-id-type="pmid">24525165</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Lennon</surname><given-names>H</given-names></name>, <name><surname>Sperrin</surname><given-names>M</given-names></name>, <name><surname>Badrick</surname><given-names>E</given-names></name>, <name><surname>Renehan</surname><given-names>AG</given-names></name>. <article-title>The Obesity Paradox in Cancer: a Review</article-title>. <source>Curr Oncol Rep</source>. <year>2016</year>;<volume>18</volume>(<issue>9</issue>):<fpage>56</fpage>. Epub 2016/08/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11912-016-0539-4</pub-id> .<pub-id pub-id-type="pmid">27475805</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Dhana</surname><given-names>K</given-names></name>, <name><surname>Koolhaas</surname><given-names>CM</given-names></name>, <name><surname>van Rossum</surname><given-names>EF</given-names></name>, <name><surname>Ikram</surname><given-names>MA</given-names></name>, <name><surname>Hofman</surname><given-names>A</given-names></name>, <name><surname>Kavousi</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly Population</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>(<issue>4</issue>):<fpage>e0154273</fpage>. Epub 2016/04/23. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0154273</pub-id> .<pub-id pub-id-type="pmid">27100779</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Powell-Wiley</surname><given-names>TM</given-names></name>, <name><surname>Poirier</surname><given-names>P</given-names></name>, <name><surname>Burke</surname><given-names>LE</given-names></name>, <name><surname>Despr&#x000e9;s</surname><given-names>JP</given-names></name>, <name><surname>Gordon-Larsen</surname><given-names>P</given-names></name>, <name><surname>Lavie</surname><given-names>CJ</given-names></name>, <etal>et al</etal>. <article-title>Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association</article-title>. <source>Circulation</source>. <year>2021</year>;<volume>143</volume>(<issue>21</issue>):<fpage>e984</fpage>&#x02013;<lpage>e1010</lpage>. Epub 2021/04/23. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/CIR.0000000000000973</pub-id> .<pub-id pub-id-type="pmid">33882682</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Petrelli</surname><given-names>F</given-names></name>, <name><surname>Cortellini</surname><given-names>A</given-names></name>, <name><surname>Indini</surname><given-names>A</given-names></name>, <name><surname>Tomasello</surname><given-names>G</given-names></name>, <name><surname>Ghidini</surname><given-names>M</given-names></name>, <name><surname>Nigro</surname><given-names>O</given-names></name>, <etal>et al</etal>. <article-title>Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis</article-title>. <source>JAMA Netw Open</source>. <year>2021</year>;<volume>4</volume>(<issue>3</issue>):<fpage>e213520</fpage>. Epub 2021/03/30. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.3520</pub-id> .<pub-id pub-id-type="pmid">33779745</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Cao</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Bunjhoo</surname><given-names>H</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Xiong</surname><given-names>W</given-names></name>. <article-title>Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>8</issue>):<fpage>e43892</fpage>. Epub 2012/09/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0043892</pub-id> .<pub-id pub-id-type="pmid">22937118</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>SY</given-names></name>, <name><surname>Wilkens</surname><given-names>LR</given-names></name>, <name><surname>Maskarinec</surname><given-names>G</given-names></name>, <name><surname>Haiman</surname><given-names>CA</given-names></name>, <name><surname>Kolonel</surname><given-names>LN</given-names></name>, <name><surname>Marchand</surname><given-names>LL</given-names></name>. <article-title>Weight change in older adults and mortality: the Multiethnic Cohort Study</article-title>. <source>Int J Obes (Lond)</source>. <year>2018</year>;<volume>42</volume>(<issue>2</issue>):<fpage>205</fpage>&#x02013;<lpage>12</lpage>. Epub 2017/09/09. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ijo.2017.188</pub-id> .<pub-id pub-id-type="pmid">28885999</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>M</given-names></name>, <name><surname>Yi</surname><given-names>Y</given-names></name>, <name><surname>Roebothan</surname><given-names>B</given-names></name>, <name><surname>Colbourne</surname><given-names>J</given-names></name>, <name><surname>Maddalena</surname><given-names>V</given-names></name>, <name><surname>Sun</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Trajectories of body mass index among Canadian seniors and associated mortality risk</article-title>. <source>BMC Public Health</source>. <year>2017</year>;<volume>17</volume>(<issue>1</issue>):<fpage>929</fpage>. Epub 2017/12/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12889-017-4917-0</pub-id> .<pub-id pub-id-type="pmid">29202810</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Crimmins</surname><given-names>EM</given-names></name>, <name><surname>Shim</surname><given-names>H</given-names></name>, <name><surname>Zhang</surname><given-names>YS</given-names></name>, <name><surname>Kim</surname><given-names>JK</given-names></name>. <article-title>Differences between Men and Women in Mortality and the Health Dimensions of the Morbidity Process</article-title>. <source>Clin Chem</source>. <year>2019</year>;<volume>65</volume>(<issue>1</issue>):<fpage>135</fpage>&#x02013;<lpage>45</lpage>. Epub 2018/11/28. <comment>doi: </comment><pub-id pub-id-type="doi">10.1373/clinchem.2018.288332</pub-id> .<pub-id pub-id-type="pmid">30478135</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref017"><label>17</label><mixed-citation publication-type="other">Chang L, Tsai S, Wang M, Liu T, Jhao J, Chuang Y, et al. MJ Health Database, MJ Health Research Foundation Technical Report, MJHRF-TR-0. 2016.</mixed-citation></ref><ref id="pone.0295919.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>TC</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Lin</surname><given-names>BC</given-names></name>, <name><surname>Lin</surname><given-names>C</given-names></name>, <name><surname>Deng</surname><given-names>HB</given-names></name>, <name><surname>Chuang</surname><given-names>YC</given-names></name>, <etal>et al</etal>. <article-title>Long-Term Exposure to Ambient Fine Particulate Matter and Chronic Kidney Disease: A Cohort Study</article-title>. <source>Environ Health Perspect</source>. <year>2018</year>;<volume>126</volume>(<issue>10</issue>):<fpage>107002</fpage>. Epub 2018/11/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1289/EHP3304</pub-id> .<pub-id pub-id-type="pmid">30392394</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>C</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Lau</surname><given-names>AKH</given-names></name>, <name><surname>Lin</surname><given-names>CQ</given-names></name>, <name><surname>Chuang</surname><given-names>YC</given-names></name>, <name><surname>Chan</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Effect of long-term exposure to fine particulate matter on lung function decline and risk of chronic obstructive pulmonary disease in Taiwan: a longitudinal, cohort study</article-title>. <source>Lancet Planet Health</source>. <year>2018</year>;<volume>2</volume>(<issue>3</issue>):<fpage>e114</fpage>&#x02013;<lpage>e25</lpage>. Epub 2018/04/05. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2542-5196(18)30028-7</pub-id> .<pub-id pub-id-type="pmid">29615226</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Martinez-Gomez</surname><given-names>D</given-names></name>, <name><surname>Ortega</surname><given-names>FB</given-names></name>, <name><surname>Hamer</surname><given-names>M</given-names></name>, <name><surname>Lopez-Garcia</surname><given-names>E</given-names></name>, <name><surname>Struijk</surname><given-names>E</given-names></name>, <name><surname>Sadarangani</surname><given-names>KP</given-names></name>, <etal>et al</etal>. <article-title>Physical Activity and Risk of Metabolic Phenotypes of Obesity: A Prospective Taiwanese Cohort Study in More Than 200,000 Adults</article-title>. <source>Mayo Clin Proc</source>. <year>2019</year>;<volume>94</volume>(<issue>11</issue>):<fpage>2209</fpage>&#x02013;<lpage>19</lpage>. Epub 2019/10/18. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.mayocp.2019.04.042</pub-id> .<pub-id pub-id-type="pmid">31619366</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Tu</surname><given-names>H</given-names></name>, <name><surname>Wen</surname><given-names>CP</given-names></name>, <name><surname>Tsai</surname><given-names>SP</given-names></name>, <name><surname>Chow</surname><given-names>WH</given-names></name>, <name><surname>Wen</surname><given-names>C</given-names></name>, <name><surname>Ye</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Cancer risk associated with chronic diseases and disease markers: prospective cohort study</article-title>. <source>Bmj</source>. <year>2018</year>;<volume>360</volume>:<fpage>k134</fpage>. Epub 2018/02/02. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.k134</pub-id> .<pub-id pub-id-type="pmid">29386192</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Tsai</surname><given-names>SP</given-names></name>, <name><surname>Tsao</surname><given-names>CK</given-names></name>, <name><surname>Chiu</surname><given-names>ML</given-names></name>, <name><surname>Tsai</surname><given-names>MK</given-names></name>, <name><surname>Lu</surname><given-names>PJ</given-names></name>, <etal>et al</etal>. <article-title>Cohort Profile: The Taiwan MJ Cohort: half a million Chinese with repeated health surveillance data</article-title>. <source>Int J Epidemiol</source>. <year>2017</year>;<volume>46</volume>(<issue>6</issue>):<fpage>1744</fpage>-g. Epub 2017/02/17. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ije/dyw282</pub-id> .<pub-id pub-id-type="pmid">28204597</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Weir</surname><given-names>CB</given-names></name>, <name><surname>Jan</surname><given-names>A</given-names></name>. <source>BMI classification percentile and cut off points</source>. <year>2019</year>.</mixed-citation></ref><ref id="pone.0295919.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>BL</given-names></name>, <name><surname>Nagin</surname><given-names>DS</given-names></name>. <article-title>Advances in Group-Based Trajectory Modeling and an SAS Procedure for Estimating Them</article-title>. <source>Sociological Methods &#x00026; Research</source>. <year>2007</year>;<volume>35</volume>(<issue>4</issue>):<fpage>542</fpage>&#x02013;<lpage>71</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/0049124106292364</pub-id></mixed-citation></ref><ref id="pone.0295919.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Nagin</surname><given-names>DS</given-names></name>, <name><surname>Odgers</surname><given-names>CL</given-names></name>. <article-title>Group-based trajectory modeling in clinical research</article-title>. <source>Annu Rev Clin Psychol</source>. <year>2010</year>;<volume>6</volume>:<fpage>109</fpage>&#x02013;<lpage>38</lpage>. Epub 2010/03/03. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev.clinpsy.121208.131413</pub-id> .<pub-id pub-id-type="pmid">20192788</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Korn</surname><given-names>EL</given-names></name>, <name><surname>Graubard</surname><given-names>BI</given-names></name>, <name><surname>Midthune</surname><given-names>D</given-names></name>. <article-title>Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale</article-title>. <source>Am J Epidemiol</source>. <year>1997</year>;<volume>145</volume>(<issue>1</issue>):<fpage>72</fpage>&#x02013;<lpage>80</lpage>. Epub 1997/01/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a009034</pub-id> .<pub-id pub-id-type="pmid">8982025</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Wolbers</surname><given-names>M</given-names></name>, <name><surname>Koller</surname><given-names>MT</given-names></name>, <name><surname>Witteman</surname><given-names>JC</given-names></name>, <name><surname>Steyerberg</surname><given-names>EW</given-names></name>. <article-title>Prognostic models with competing risks: methods and application to coronary risk prediction</article-title>. <source>Epidemiology</source>. <year>2009</year>;<volume>20</volume>(<issue>4</issue>):<fpage>555</fpage>&#x02013;<lpage>61</lpage>. Epub 2009/04/16. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/EDE.0b013e3181a39056</pub-id> .<pub-id pub-id-type="pmid">19367167</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>M</given-names></name>, <name><surname>Yi</surname><given-names>Y</given-names></name>, <name><surname>Roebothan</surname><given-names>B</given-names></name>, <name><surname>Colbourne</surname><given-names>J</given-names></name>, <name><surname>Maddalena</surname><given-names>V</given-names></name>, <name><surname>Wang</surname><given-names>PP</given-names></name>, <etal>et al</etal>. <article-title>Body Mass Index Trajectories among Middle-Aged and Elderly Canadians and Associated Health Outcomes</article-title>. <source>J Environ Public Health</source>. <year>2016</year>;<volume>2016</volume>:<fpage>7014857</fpage>. Epub 2016/03/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2016/7014857</pub-id> .<pub-id pub-id-type="pmid">26925112</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Zajacova</surname><given-names>A</given-names></name>, <name><surname>Huzurbazar</surname><given-names>S</given-names></name>, <name><surname>Greenwood</surname><given-names>M</given-names></name>, <name><surname>Nguyen</surname><given-names>H</given-names></name>. <article-title>Long-Term BMI Trajectories and Health in Older Adults: Hierarchical Clustering of Functional Curves</article-title>. <source>J Aging Health</source>. <year>2015</year>;<volume>27</volume>(<issue>8</issue>):<fpage>1443</fpage>&#x02013;<lpage>61</lpage>. Epub 2015/05/09. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/0898264315584329</pub-id> .<pub-id pub-id-type="pmid">25953813</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Dugu&#x000e9;</surname><given-names>PA</given-names></name>, <name><surname>Lynch</surname><given-names>BM</given-names></name>, <name><surname>Hodge</surname><given-names>AM</given-names></name>, <name><surname>Karahalios</surname><given-names>A</given-names></name>, <name><surname>MacInnis</surname><given-names>RJ</given-names></name>, <etal>et al</etal>. <article-title>Trajectories of body mass index in adulthood and all-cause and cause-specific mortality in the Melbourne Collaborative Cohort Study</article-title>. <source>BMJ Open</source>. <year>2019</year>;<volume>9</volume>(<issue>8</issue>):<fpage>e030078</fpage>. Epub 2019/08/12. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjopen-2019-030078</pub-id> .<pub-id pub-id-type="pmid">31401610</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Peter</surname><given-names>RS</given-names></name>, <name><surname>Keller</surname><given-names>F</given-names></name>, <name><surname>Klenk</surname><given-names>J</given-names></name>, <name><surname>Concin</surname><given-names>H</given-names></name>, <name><surname>Nagel</surname><given-names>GJM</given-names></name>. <article-title>Body mass trajectories, diabetes mellitus, and mortality in a large cohort of Austrian adults</article-title>. <source>J Medicine</source>
<year>2016</year>;<volume>95</volume>(<issue>49</issue>).</mixed-citation></ref><ref id="pone.0295919.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Flicker</surname><given-names>L</given-names></name>, <name><surname>McCaul</surname><given-names>KA</given-names></name>, <name><surname>Hankey</surname><given-names>GJ</given-names></name>, <name><surname>Jamrozik</surname><given-names>K</given-names></name>, <name><surname>Brown</surname><given-names>WJ</given-names></name>, <name><surname>Byles</surname><given-names>JE</given-names></name>, <etal>et al</etal>. <article-title>Body mass index and survival in men and women aged 70 to 75</article-title>. <source>J Am Geriatr Soc</source>. <year>2010</year>;<volume>58</volume>(<issue>2</issue>):<fpage>234</fpage>&#x02013;<lpage>41</lpage>. Epub 2010/04/08. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1532-5415.2009.02677.x</pub-id> .<pub-id pub-id-type="pmid">20370857</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Inoue</surname><given-names>K</given-names></name>, <name><surname>Shono</surname><given-names>T</given-names></name>, <name><surname>Toyokawa</surname><given-names>S</given-names></name>, <name><surname>Kawakami</surname><given-names>M</given-names></name>. <article-title>Body mass index as a predictor of mortality in community-dwelling seniors</article-title>. <source>Aging Clin Exp Res</source>. <year>2006</year>;<volume>18</volume>(<issue>3</issue>):<fpage>205</fpage>&#x02013;<lpage>10</lpage>. Epub 2006/06/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/BF03324650</pub-id> .<pub-id pub-id-type="pmid">16804366</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Grabowski</surname><given-names>DC</given-names></name>, <name><surname>Ellis</surname><given-names>JE</given-names></name>. <article-title>High body mass index does not predict mortality in older people: analysis of the Longitudinal Study of Aging</article-title>. <source>J Am Geriatr Soc</source>. <year>2001</year>;<volume>49</volume>(<issue>7</issue>):<fpage>968</fpage>&#x02013;<lpage>79</lpage>. Epub 2001/08/31. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1532-5415.2001.49189.x</pub-id> .<pub-id pub-id-type="pmid">11527490</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Puzianowska-Kuznicka</surname><given-names>M</given-names></name>, <name><surname>Kury&#x00142;owicz</surname><given-names>A</given-names></name>, <name><surname>Walkiewicz</surname><given-names>D</given-names></name>, <name><surname>Borkowska</surname><given-names>J</given-names></name>, <name><surname>Owczarz</surname><given-names>M</given-names></name>, <name><surname>Olszanecka-Glinianowicz</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Obesity Paradox in Caucasian Seniors: Results of the PolSenior Study</article-title>. <source>J Nutr Health Aging</source>. <year>2019</year>;<volume>23</volume>(<issue>9</issue>):<fpage>796</fpage>&#x02013;<lpage>804</lpage>. Epub 2019/10/24. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s12603-019-1257-z</pub-id> .<pub-id pub-id-type="pmid">31641728</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Nozoe</surname><given-names>T</given-names></name>, <name><surname>Oyama</surname><given-names>T</given-names></name>, <name><surname>Takenoyama</surname><given-names>M</given-names></name>, <name><surname>Hanagiri</surname><given-names>T</given-names></name>, <name><surname>Sugio</surname><given-names>K</given-names></name>, <name><surname>Yasumoto</surname><given-names>K</given-names></name>. <article-title>Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus</article-title>. <source>Clin Cancer Res</source>. <year>2007</year>;<volume>13</volume>(<issue>14</issue>):<fpage>4046</fpage>&#x02013;<lpage>50</lpage>. Epub 2007/07/20. <comment>doi: </comment><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-07-0449</pub-id> .<pub-id pub-id-type="pmid">17634528</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Sukocheva</surname><given-names>OA</given-names></name>. <article-title>Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet?</article-title>
<source>World J Gastroenterol</source>. <year>2018</year>;<volume>24</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>4</lpage>. Epub 2018/01/24. <comment>doi: </comment><pub-id pub-id-type="doi">10.3748/wjg.v24.i1.1</pub-id> .<pub-id pub-id-type="pmid">29358876</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>B</given-names></name>, <name><surname>Zhu</surname><given-names>YJ</given-names></name>, <name><surname>Wang</surname><given-names>HY</given-names></name>, <name><surname>Chen</surname><given-names>L</given-names></name>. <article-title>Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms</article-title>. <source>Sci China Life Sci</source>. <year>2017</year>;<volume>60</volume>(<issue>6</issue>):<fpage>575</fpage>&#x02013;<lpage>84</lpage>. Epub 2017/05/27. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11427-016-9043-9</pub-id> .<pub-id pub-id-type="pmid">28547581</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Stevanato Filho</surname><given-names>PR</given-names></name>, <name><surname>Aguiar J&#x000fa;nior</surname><given-names>S</given-names></name>, <name><surname>Begnami</surname><given-names>MD</given-names></name>, <name><surname>Ferreira</surname><given-names>FO</given-names></name>, <name><surname>Nakagawa</surname><given-names>WT</given-names></name>, <name><surname>Spencer</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Estrogen Receptor &#x003b2; as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic Polyps</article-title>. <source>Pathol Oncol Res</source>. <year>2018</year>;<volume>24</volume>(<issue>3</issue>):<fpage>533</fpage>&#x02013;<lpage>40</lpage>. Epub 2017/07/07. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s12253-017-0268-5</pub-id> .<pub-id pub-id-type="pmid">28681123</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>HA</given-names></name>, <name><surname>Albert</surname><given-names>LM</given-names></name>, <name><surname>Leathurby</surname><given-names>Y</given-names></name>, <name><surname>Malamas</surname><given-names>MS</given-names></name>, <name><surname>Mewshaw</surname><given-names>RE</given-names></name>, <name><surname>Miller</surname><given-names>CP</given-names></name>, <etal>et al</etal>. <article-title>Evaluation of an estrogen receptor-&#x003b2; agonist in animal models of human disease</article-title>. <source>Endocrinology</source>. <year>2003</year>;<volume>144</volume>(<issue>10</issue>):<fpage>4241</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">14500559</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Folkerd</surname><given-names>EJ</given-names></name>, <name><surname>Dowsett</surname><given-names>M</given-names></name>. <article-title>Influence of sex hormones on cancer progression</article-title>. <source>J Clin Oncol</source>. <year>2010</year>;<volume>28</volume>(<issue>26</issue>):<fpage>4038</fpage>&#x02013;<lpage>44</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1200/JCO.2009.27.4290</pub-id>
<pub-id pub-id-type="pmid">20644089</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Freeman</surname><given-names>EW</given-names></name>, <name><surname>Sammel</surname><given-names>MD</given-names></name>, <name><surname>Lin</surname><given-names>H</given-names></name>, <name><surname>Gracia</surname><given-names>CR</given-names></name>. <article-title>Obesity and reproductive hormone levels in the transition to menopause</article-title>. <source>Menopause</source>. <year>2010</year>;<volume>17</volume>(<issue>4</issue>):<fpage>718</fpage>&#x02013;<lpage>26</lpage>. Epub 2010/03/11. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/gme.0b013e3181cec85d</pub-id> .<pub-id pub-id-type="pmid">20216473</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Dorak</surname><given-names>MT</given-names></name>, <name><surname>Karpuzoglu</surname><given-names>E</given-names></name>. <article-title>Gender differences in cancer susceptibility: an inadequately addressed issue</article-title>. <source>Front Genet</source>. <year>2012</year>;<volume>3</volume>:<fpage>268</fpage>. Epub 2012/12/12. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fgene.2012.00268</pub-id> .<pub-id pub-id-type="pmid">23226157</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>HI</given-names></name>, <name><surname>Lim</surname><given-names>H</given-names></name>, <name><surname>Moon</surname><given-names>A</given-names></name>. <article-title>Sex Differences in Cancer: Epidemiology, Genetics and Therapy</article-title>. <source>Biomol Ther (Seoul)</source>. <year>2018</year>;<volume>26</volume>(<issue>4</issue>):<fpage>335</fpage>&#x02013;<lpage>42</lpage>. Epub 2018/06/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.4062/biomolther.2018.103</pub-id> .<pub-id pub-id-type="pmid">29949843</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Ruzzo</surname><given-names>A</given-names></name>, <name><surname>Graziano</surname><given-names>F</given-names></name>, <name><surname>Galli</surname><given-names>F</given-names></name>, <name><surname>Galli</surname><given-names>F</given-names></name>, <name><surname>Rulli</surname><given-names>E</given-names></name>, <name><surname>Lonardi</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy</article-title>. <source>Sci Rep</source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>11527</fpage>. Epub 2019/08/10. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-019-47627-1</pub-id> .<pub-id pub-id-type="pmid">31395900</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Joerger</surname><given-names>M</given-names></name>, <name><surname>Huitema</surname><given-names>AD</given-names></name>, <name><surname>van den Bongard</surname><given-names>DH</given-names></name>, <name><surname>Schellens</surname><given-names>JH</given-names></name>, <name><surname>Beijnen</surname><given-names>JH</given-names></name>. <article-title>Quantitative effect of gender, age, liver function, and body size on the population pharmacokinetics of Paclitaxel in patients with solid tumors</article-title>. <source>Clin Cancer Res</source>. <year>2006</year>;<volume>12</volume>(<issue>7 Pt 1</issue>):<fpage>2150</fpage>&#x02013;<lpage>7</lpage>. Epub 2006/04/13. <comment>doi: </comment><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-05-2069</pub-id> .<pub-id pub-id-type="pmid">16609028</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Anzueto</surname><given-names>A</given-names></name>, <name><surname>Wise</surname><given-names>R</given-names></name>, <name><surname>Calverley</surname><given-names>P</given-names></name>, <name><surname>Dusser</surname><given-names>D</given-names></name>, <name><surname>Tang</surname><given-names>W</given-names></name>, <name><surname>Metzdorf</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>The Tiotropium Safety and Performance in Respimat<sup>&#x000ae;</sup> (TIOSPIR<sup>&#x000ae;</sup>) Trial: Spirometry Outcomes</article-title>. <source>Respir Res</source>. <year>2015</year>;<volume>16</volume>(<issue>1</issue>):<fpage>107</fpage>. Epub 2015/09/16. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12931-015-0269-4</pub-id> .<pub-id pub-id-type="pmid">26369563</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>T</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Yu</surname><given-names>F</given-names></name>, <name><surname>Xu</surname><given-names>Q</given-names></name>, <name><surname>Guo</surname><given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis</article-title>. <source>Medicine (Baltimore)</source>. <year>2016</year>;<volume>95</volume>(<issue>28</issue>):<fpage>e4225</fpage>. Epub 2016/07/20. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/MD.0000000000004225</pub-id> .<pub-id pub-id-type="pmid">27428228</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Putcha</surname><given-names>N</given-names></name>, <name><surname>Anzueto</surname><given-names>AR</given-names></name>, <name><surname>Calverley</surname><given-names>PMA</given-names></name>, <name><surname>Celli</surname><given-names>BR</given-names></name>, <name><surname>Tashkin</surname><given-names>DP</given-names></name>, <name><surname>Metzdorf</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT</article-title>. <source>Ann Am Thorac Soc</source>. <year>2022</year>;<volume>19</volume>(<issue>2</issue>):<fpage>204</fpage>&#x02013;<lpage>13</lpage>. Epub 2021/08/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.1513/AnnalsATS.202006-722OC</pub-id> .<pub-id pub-id-type="pmid">34406915</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Milne</surname><given-names>S</given-names></name>, <name><surname>Jaw</surname><given-names>JE</given-names></name>, <name><surname>Yang</surname><given-names>CX</given-names></name>, <name><surname>Xu</surname><given-names>F</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <etal>et al</etal>. <article-title>BMI is associated with FEV(1) decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials</article-title>. <source>Respir Res</source>. <year>2019</year>;<volume>20</volume>(<issue>1</issue>):<fpage>236</fpage>. Epub 2019/10/31. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12931-019-1209-5</pub-id> non-financial support from Draeger Australia, outside the submitted work. DDS reports grants from Merck, personal fees from Sanofi-Aventis, Regeneron and Novartis, and grants and personal fees from Boehringer Ingelheim and AstraZeneca, outside the submitted work. YS, JEJ, CXY, FX, XL, and MO have nothing to disclose.<pub-id pub-id-type="pmid">31665000</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Tkacova</surname><given-names>R</given-names></name>, <name><surname>Dai</surname><given-names>DLY</given-names></name>, <name><surname>Vonk</surname><given-names>JM</given-names></name>, <name><surname>Leung</surname><given-names>JM</given-names></name>, <name><surname>Hiemstra</surname><given-names>PS</given-names></name>, <name><surname>van den Berge</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Airway hyperresponsiveness in chronic obstructive pulmonary disease: A marker of asthma-chronic obstructive pulmonary disease overlap syndrome?</article-title>
<source>J Allergy Clin Immunol</source>. <year>2016</year>;<volume>138</volume>(<issue>6</issue>):<fpage>1571</fpage>&#x02013;<lpage>9.e10</lpage>. Epub 2016/06/28. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jaci.2016.04.022</pub-id> .<pub-id pub-id-type="pmid">27345171</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Cogen</surname><given-names>J</given-names></name>, <name><surname>Emerson</surname><given-names>J</given-names></name>, <name><surname>Sanders</surname><given-names>DB</given-names></name>, <name><surname>Ren</surname><given-names>C</given-names></name>, <name><surname>Schechter</surname><given-names>MS</given-names></name>, <name><surname>Gibson</surname><given-names>RL</given-names></name>, <etal>et al</etal>. <article-title>Risk factors for lung function decline in a large cohort of young cystic fibrosis patients</article-title>. <source>Pediatr Pulmonol</source>. <year>2015</year>;<volume>50</volume>(<issue>8</issue>):<fpage>763</fpage>&#x02013;<lpage>70</lpage>. Epub 2015/06/11. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/ppul.23217</pub-id> .<pub-id pub-id-type="pmid">26061914</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Stav</surname><given-names>D</given-names></name>, <name><surname>Raz</surname><given-names>M</given-names></name>, <name><surname>Shpirer</surname><given-names>I</given-names></name>. <article-title>Three years of pulmonary rehabilitation: inhibit the decline in airflow obstruction, improves exercise endurance time, and body-mass index, in chronic obstructive pulmonary disease</article-title>. <source>BMC Pulm Med</source>. <year>2009</year>;<volume>9</volume>:<fpage>26</fpage>. Epub 2009/06/02. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2466-9-26</pub-id> .<pub-id pub-id-type="pmid">19480709</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Do</surname><given-names>JG</given-names></name>, <name><surname>Park</surname><given-names>CH</given-names></name>, <name><surname>Lee</surname><given-names>YT</given-names></name>, <name><surname>Yoon</surname><given-names>KJ</given-names></name>. <article-title>Association between underweight and pulmonary function in 282,135 healthy adults: A cross-sectional study in Korean population</article-title>. <source>Sci Rep</source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>14308</fpage>. Epub 2019/10/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-019-50488-3</pub-id> .<pub-id pub-id-type="pmid">31586079</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Wan</surname><given-names>ES</given-names></name>, <name><surname>Cho</surname><given-names>MH</given-names></name>, <name><surname>Boutaoui</surname><given-names>N</given-names></name>, <name><surname>Klanderman</surname><given-names>BJ</given-names></name>, <name><surname>Sylvia</surname><given-names>JS</given-names></name>, <name><surname>Ziniti</surname><given-names>JP</given-names></name>, <etal>et al</etal>. <article-title>Genome-wide association analysis of body mass in chronic obstructive pulmonary disease</article-title>. <source>Am J Respir Cell Mol Biol</source>. <year>2011</year>;<volume>45</volume>(<issue>2</issue>):<fpage>304</fpage>&#x02013;<lpage>10</lpage>. Epub 2010/11/03. <comment>doi: </comment><pub-id pub-id-type="doi">10.1165/rcmb.2010-0294OC</pub-id> .<pub-id pub-id-type="pmid">21037115</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Ahmad</surname><given-names>T</given-names></name>, <name><surname>Lee</surname><given-names>IM</given-names></name>, <name><surname>Par&#x000e9;</surname><given-names>G</given-names></name>, <name><surname>Chasman</surname><given-names>DI</given-names></name>, <name><surname>Rose</surname><given-names>L</given-names></name>, <name><surname>Ridker</surname><given-names>PM</given-names></name>, <etal>et al</etal>. <article-title>Lifestyle interaction with fat mass and obesity-associated (FTO) genotype and risk of obesity in apparently healthy U.S. women</article-title>. <source>Diabetes Care</source>. <year>2011</year>;<volume>34</volume>(<issue>3</issue>):<fpage>675</fpage>&#x02013;<lpage>80</lpage>. Epub 2011/01/27. <comment>doi: </comment><pub-id pub-id-type="doi">10.2337/dc10-0948</pub-id> .<pub-id pub-id-type="pmid">21266646</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Kalantari</surname><given-names>N</given-names></name>, <name><surname>Doaei</surname><given-names>S</given-names></name>, <name><surname>Keshavarz-Mohammadi</surname><given-names>N</given-names></name>, <name><surname>Gholamalizadeh</surname><given-names>M</given-names></name>, <name><surname>Pazan</surname><given-names>N</given-names></name>. <article-title>Review of studies on the fat mass and obesity-associated (FTO) gene interactions with environmental factors affecting on obesity and its impact on lifestyle interventions</article-title>. <source>ARYA Atheroscler</source>. <year>2016</year>;<volume>12</volume>(<issue>6</issue>):<fpage>281</fpage>&#x02013;<lpage>90</lpage>. Epub 2017/06/14. .<pub-id pub-id-type="pmid">28607568</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Nuttall</surname><given-names>FQ</given-names></name>. <article-title>Body Mass Index: Obesity, BMI, and Health: A Critical Review</article-title>. <source>Nutr Today</source>. <year>2015</year>;<volume>50</volume>(<issue>3</issue>):<fpage>117</fpage>&#x02013;<lpage>28</lpage>. Epub 2016/06/25. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/NT.0000000000000092</pub-id> .<pub-id pub-id-type="pmid">27340299</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Sahakyan</surname><given-names>KR</given-names></name>, <name><surname>Somers</surname><given-names>VK</given-names></name>, <name><surname>Rodriguez-Escudero</surname><given-names>JP</given-names></name>, <name><surname>Hodge</surname><given-names>DO</given-names></name>, <name><surname>Carter</surname><given-names>RE</given-names></name>, <name><surname>Sochor</surname><given-names>O</given-names></name>, <etal>et al</etal>. <article-title>Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality</article-title>. <source>Ann Intern Med</source>. <year>2015</year>;<volume>163</volume>(<issue>11</issue>):<fpage>827</fpage>&#x02013;<lpage>35</lpage>. Epub 2015/11/10. <comment>doi: </comment><pub-id pub-id-type="doi">10.7326/M14-2525</pub-id> .<pub-id pub-id-type="pmid">26551006</pub-id>
</mixed-citation></ref><ref id="pone.0295919.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>KW</given-names></name>, <name><surname>Marcus</surname><given-names>MD</given-names></name>, <name><surname>El ghormli</surname><given-names>L</given-names></name>, <name><surname>Ogden</surname><given-names>CL</given-names></name>, <name><surname>Foster</surname><given-names>GD</given-names></name>. <article-title>Cardio-metabolic risk screening among adolescents: understanding the utility of body mass index, waist circumference and waist to height ratio</article-title>. <source>Pediatr Obes</source>. <year>2015</year>;<volume>10</volume>(<issue>5</issue>):<fpage>329</fpage>&#x02013;<lpage>37</lpage>. Epub 2014/12/18. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/ijpo.267</pub-id> .<pub-id pub-id-type="pmid">25515620</pub-id>
</mixed-citation></ref></ref-list></back></article>
